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Breakthroughs in tissue engineering are moving at a rapid rate, especially 
in regenerative bone biofabrication.  Technology growth in the field of additive 
manufacturing (AM) such as 3D bioprinting which provides the ability to create a 
biocompatible 3D construct on which a cell source could be seeded is an 
encouraging substitute to autologous grafts.   
 This present research aims to biofabricate a construct for bone tissue 
engineering using AM technology.  The biocompatible material was chosen 
corresponding to the skeletons extracellular matrix (ECM) composition, which 
demonstrates an inorganic and organic development phase: Poly (lactic-glycolic 
acid) was chosen as the polymeric matrix of the compound, due to its bioactivity, 
biocompatibility, and ability to regulate biodegradability to support cell and bone 
function; graphene-nanoparticle were chosen for mechanical and organic 
reinforcement to support the mineral phase of the ECM.   
 A commercial 3D bioprinter called the Aether 1 was used.  The printer is a 
pneumatic based printer, which allows printing from hydrogels to thermo 
polymers.  The bioprinter is located in the Regenerative Medicine Lab in the 
Large Animal Clinical Sciences.    
 The first part of our study was to show the relationship of mesenchymal 
stem cells and graphene-nanoparticles. This was to evaluate the ECM layout on 
the graphene for biocompatibility and establish markers for supporting 
osteogenesis.  Second part of the research dealt with finding a safe solvent to 
melt the different molar ratios of PLGA and the blending in of graphene-
nanoparticles for low thermodynamic and low-pressure printing.  This work dealt 
with the characterization, constating in the evaluation of different extrusion 
speeds, pressure values and nozzle diameters to construct a 3D print for testing 
the biocompatibility and cellular behavior.  The final study was to utilize the 3D 




 This work proved that the biofabrication of the PLGA+graphene 
nanoparticle blend could be achieved and repeatable with 3D bioprinting, 
supports cellular behavior for regeneration and provided results in the long bone 
defect study.   
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Nearly thirty years ago a technology was brought to light that had no 
understanding how it would change science, medicine and manufacturing.  The 
production of 3D models used in many avenues has grown greatly over the years.  The 
reviewed literature works has gone back many years, but this review will cover a period 
of the last 10-15 years when printing manufactures entered, and 3D printing grew at a 
pace from only structure formations to new construct biocompatible materials with stem 
cells and supporting components. This chapter outlines the application of 3D printing in 
tissue and organ regeneration, productions of new materials for fabrication and 
biofabrication and its effects on economics for this technology. Stereolithography is 
what Hull, 3D printing inventor, called his first 3D printing automation. He secured a 
patent for his invention and established a 3D System to make and commercialize 3D 
































To heal or replace, which treatment for tissue damage or organ failure?  This is 
where regenerative medicine comes into play with a goal to engineer tissues for 
transplantation and replacement. This is primarily due to organ shortage and the tool to 
aid in this task of bio-manufacturing is three-dimensional printing or bioprinting. The 
goal of 3D printing is to meet the need and match patient specific resolution.  The 
approach of 3D bioprinting is a growing application for multiple tissue engineering 
challenges with tissue regeneration being the end goal. The body of any animal is 
profoundly complex with a multiplex of tissue types.  Organs of these complex systems 
are formed by extremely specialized cells with complex functions.  Three-dimensional 
framework of multicellular tissues defines different roles, providing organ structural 
integrity but also indicate functional organ perimeters and depict the microenvironment 
niche (Mecham, 2012).  With an avenue of cells, bioactive/growth molecules or factors 
and a scaffold, it is imperative to consolidate the foundation of cellular and molecular 
biology with material science to form the cocktail to engineer this needed 3D 
environment. Controlling and understanding the cellular surroundings is a vital step for 
engineering a material for cellular function (Jiang, 2003). No matter the application or 
the need, the approach is to achieve cell survival with an objective for the restoration 
and function of a tissue.  Regardless of the strategic approach the ultimate host 
response to the implanted construct will direct the accomplishment or collapse of 3D 
bioprinting. 
 Many primary cell lineages are complex to isolate and culture in vitro with a 
narrow lifespan (Dimri, 1995).  Mesenchymal stem cells (MSCs) which can be isolated 
from any adult somatic tissue have the potential to self-renew and differentiate leading 
to an unlimited cell source for tissue regeneration when they are combined with a well-
developed 3D bioprinted/-biofabricated construct.  The stem cell niche is a convoluted 
3D environment which impacts cell fate. Within the stem cell system, the exchange of 
oxygen and growth factors, cell-cell association as well as cell-matrix adherence are 
required for regulation (Discher, 2009). Therefore, the accurate biofabrication of this 




medicine.  The construction of stem cell niches and tissue constructs is very challenging 
from a technical point of view because of their complexity.  
 By this measure there is a demand to cultivate a genuine matrix substitute 
to replace traditional 3D scaffolds.  Bioprinting is an additive manufacturing (AM), where 
the scaffold design for fabrication layout starts with computer-aid design (CAD) 
software, then data is transferred into a code that directs the 3D printer to print in a 
layer-by-layer composition (Figure 1.1).  This chapter is subdivided to include the 
details of the most common 3D printing and bioprinting technologies.  Attention has 
been placed in extrusion-based printing/bioprinting automation.  In the last section, it 
details the importance of the biofabrication in mimicking of extracellular matrix to 
improve cell survival for implantation.   
 
3D Bioprinting Building Blocks 
 
According to the National Institute of Health, tissue engineering is a strategy that 
uses a combination of cells, specifically designed and engineered materials, and 
suitable biochemical and physicochemical factors to restore, maintain, improve, or 
replace different types of biological tissues. Regenerative medicine is a broad filed of 
tissue engineering. Tissue engineering using stem cells requires the appropriate niche 
for proper proliferation and differentiation. Technically, engineering the stem cell niche is 
considered as the most challenging aspect of tissue engineering. 3D printing provides 
the three-dimensional environment for the cells and helps them to maintain their cell-cell 
contact and thus, their function. In conventional 2D cultures, primary cells rapidly lose 
their function, in large part due to distressed cell-cell contacts, further emphasizing the 
importance of 3D printing. As a result, 3D printing of materials provides a structure for 
the function of endogenous and exogenous cells.  The 3D scaffold alone i.e., an 
acellular scaffold has the potential to provide a structure for endogenous cells to 
function appropriately. It can also be combined with exogenous cell populations to 
design highly sophisticated constructs that mimic the natural tissue and hence, can be 
adapted for use of living material. The approach of 3D bioprinting of either material 




reconstruct tissue from various regions of the body. This technology can also potentially 
be applied to bone, skin, cartilage and muscle tissue.  
In 3D printing, several technical issues have to be considered before any cellular 
component can be included. These include the choice of printing technology, choice of 
the biomatrix, printing parameters, and subsequently, considerations of the interaction 
between the materials and cells. The scaffold is designed in a CAD program, then 
coded to the 3D printer for a structure formation in a layer-by-layer format. The 3D 
bioprinter is a multi-tool printer allowing for multiple fabrication methods and printing 
cells and biological materials in programed patterns and gradients. Microextrusion is the 
common choice of printing and is essentially the same as that used in thermal inkjet 
printing, which can attain a spatial resolution of hundreds of micrometers. Microjet 
extruder bioprinting is the process in which designed droplets are deposited onto the 
scaffolds in a layer-by layer preprogrammed design. The choice of the materials that 
can be printed is endless, and in biomedicine, the choice of the material is highly 
dependent on the applications and the cells that will be either printed or manually added 
onto the printed scaffold, or the nature of the cells that the implanted scaffold will be 
exposed to in the body (Tappa, 2018).   
 
Additive Manufacturing – Making Three Dimensional Scaffolds 
The additive process is the formation of a 3D printed scaffold or object. It is 
developed by the blending of materials.  The material is placed through a technology 
which creates successive layers of blended materials and a physical object is 
assembled.  The common desktop printer, the inkjet, which was brought to use in the 
seventies was attached to a computer to receive commands. This constituted the whole 
building platform for the 3D printer.  The inkjet required a data file and a computer 
connection controller to have complete operation.  A modern 3D printer also requires a 
data file based on the physical objects’ 3D model, and post-modeling code after the 
model is printed.  Metal alloy, synthetic polymers and now biological tissues must be 
considered because the choice of the material alters the processing method and hence 
is needed to achieve the needed design.  The American Society for Testing and 




additive manufacturing into seven groups based on the manufacturing process. These 
groups include material extrusion, energy direct deposition, sheet lamination, powder 
bed fusion, binder jetting, material jetting and vat photo polymerization (Picariello, 
2017).   
 
Computer-aided Design, G-code and Computer – aided Tissue Engineering 
CAD software is where 3D printing begins for the manufacturing process.  The 
operator designs a digital model of the desired architecture in the levels of macro, micro 
and nano scales for the overall shape of the needed scaffold.  In the fabrication or 
biofabrication the microarchitecture of the overall design allows for the complex 
structures of anatomical features; the micro design mirrors the tissue layout including 
pore size and interconnectivity and spatial distribution; and the nano design looks at the 
constructs’ surface properties for cell adhesion, proliferation, differentiation and 
biomolecular attachment.   CAD has allowed for complex biofabrication of 3D scaffolds 
to meet specific patient needs.  CAD software has the coding for integration of imaging 
techniques such as computer tomography and magnetic resonance imaging, thereby, 
translating the CT and the MRI images directly into the printer.  The ability of utilizing 
this technology has allowed for more advanced prototype scaffold designing, 
manipulation and biofabrication of macro to nanoarchitecture.  Once the scaffold is 
developed in the CAD software, the CAD file is converted to a standard industry format 
as a stereolithography file.  The stereolithography file is known as the STL file, 
developed by Hull, is based on a geometrical format using triangular shapes (Kwok et 
al., 2017).  The STL file is then split into layers in the layer-by-layer design by a process 
known as slicing.  The slicing software effectively translates the 3D scaffold into a 
control language known as a G-code.  A G-code is a language written in a numerical 
control program that sends a code or instructions to the printer. A G-code is specific to 
the printer or the bioprinter and the additive manufacturing method which is being 
utilized (Kwok et al., 2017). The G-code provides the language that the 3D printer can 
translate and use to print.  
The architecture of computer-aided tissue engineering (CATE) allows for 




into a complex 3D construct and be patient tissue specific.  The careful layout must 
review all levels of the macro, micro and nano components. The complexity of the 
overall macroarchitecture shape being the anatomical structure must be mimicked, the 
microarchitecture must relate closely to the tissue matrix being porosity, spatial 
distribution and interconnectivity.  The nanoarchitecture will build the strong attraction 
for cell adhesion, proliferation, and differentiation for a mature development.  Using 
CATE with micro-CT and MRI data allows for the layout for a rapid prototyping of the 
construct’s macro and micro biofabrication quality (Winder, 2005).  The support of 
CATE leads the way to a rapid prototyping, called solid free form fabrication (SFF), 
allowing the design of the construct’s complex macro and microarchitecture for detailed 
engineering. 
 
Solid Freeform (SFF) Biofabrication  
 The process of forming a 3D device is done in a layer-by-layer method with SFF 
biofabrication.  A computer model using data from a medical image such as micro-CT 
and radiology views is developed for the proper geometry.  Next, the 2D computer 
model images are software generated forming a 3D rendering.  A layer-by-layer model 
for biofabrication has the ability to input nanoarchitecture modification on any surface in 
post process if needed. The use of SFF has advantages to print complex designs, 
allowing for highly convoluted structure overhangs or volume infills.  The ability of 
processing multiples of parameters and layouts before processing, specifically with 
control of pore morphology and varying porosities at different levels of biofabrication is a 
very important manufacturing process. This becomes significant when dealing with the 
complexity of mammal anatomy.   A modified method of 3D printing, stereolithography 
(SLA), fused deposition modeling (FDM), and bioplotting are a few SFF technologies 
briefly described below.   
 
Structural Parameter - Limitations and Accuracy  
How closely does the 3D fabricated scaffold compare to the CAD file to give a 
sound call for accuracy?  Many software features and the location of the XY resolution 




Structural resolution dictates a printing system’s ability to accurately build the 
detailed features of the scaffold.  In the fabrication process, repeatability of 
measurement is processed by the printer and not the CAD design.  An important 
variable in 3D printing is spatial resolution.  Tissue extracellular matrix and construction 
varies in the hundreds of microns making this variable one of the most challenging to 
control in biofabrication.  Within most body tissues, cells need to maintain homeostasis 
staying generally no more than 100 – 200 μm away from capillaries (Lovett et al.,2009). 
Therefore, bioengineered devices and scaffolds are diffusion limited in size due to lack 
of vasculature. As a result, culturing cells at physiological densities without ample 
vascularization can lead to necrosis (Miller et al., 2012). 
 
3D Printing 
Massachusetts Institute of Technology has taken the technology to develop a 
modified version of three-dimensional printing (3DP) (Wu, 1996).  The process design 
for this method was to first build a 3D object with particles of a layer of thin loose 
powder, next the printhead deposits a liquid binder creating a pattern from the bound 
powder particles.  This was a layer-by-layer design system.  When complete, the 
designed components are removed from the print bed of powder and loose powder is 
detached.  This method of printing utilized the loose powder to support overhand 
structural features and channels within the structure.  As a result, the 3DP was 
composed of the powder and the binder.  Organic solvent such as Diethylene Glycol 
can be utilized as binders while most powders were composed of synthetic polymers 
such as poly (ε-caprolactone), polylactide–coglycolide or poly (L- lactic acid) (Wu, 
1996). Other inkjet systems used natural polymer powders such as starch, gelatin mix 
and dextran with water as the binding agent (Seitz et al., 2005).  Indirect method of 3DP 
utilizes a printed mold design which is later cast with a porogen material and polymer 
mix.  Calcium sulfate hemihydrate plaster powder with a water-based binder, is typically 
cast as the mold later mixed to form a biodegradable polymer slurry which is dissolved 
in polylactide–coglycolide in chloroform mixed with NaCl as the solvent (Lee, 2008). 
The abundant range of natural and synthetic material powder forms and the 




extensions, design with microstructure manipulation and set full adjustments to internal 
architecture gives many advantages.  The 3DP disadvantages include the limited 
organic solvents that can be used as binders due to the damage caused to the 
printhead and, secondly the powders clog small pores and curved channels within the 
construct.   
 
Stereolithography - Photopolymerization 
The design of this printer is to utilize a controlled irradiated laser or light to 
solidify the geometrically created 2D pattern through photopolymerization in the resin 
reservoir.  This method was used by Hull when 3D printing came to light (Hull, 1986).  
Overall, the primary improvement of stereolithography-based bioprinting is the ability to 
simply fabricate multiplex scaffold designs with high resolution and rapidly print 
constructs without needed support material (Murphey, S.V. and Atala, A., 2014; Park et 
al., 2017). SLA materials used are limited because they should be photocrosslinkable. 
Hence, poly (propylene fumarate) (Lee, et al., 2007) and PEG dimethacrylate 
formulations are commonly used. SLA is moving towards using biodegradable materials 
by synthesizing different polymers like macromers. SLA has a higher resolution but a 
longer print time than Fused Filament.  The future of cell work with SLA includes 
encapsulation of cells during polymerization in processed hydrogels.  The method still 
has many limitations such as cytotoxicity of the initiator and exposure to UV light, but 
teams are reviewing the needed changes including the use of hydrogels, which can 
prove very helpful in regenerative medicine.  
 
Fused Deposition or Fused Filament Printing  
This fabrication method works by building consecutive layers of a polymer at high 
temperatures, allowing the adjacent layers to cool and form a bond before the next 
deposited layer is extracted.  This fabrication method has limited resolution and 
accuracy due to the motors and print time.  Fused fabrication has the ability to be easily 
customized for scaffold designs and can be hollow or infill to save material cost.  
Depending on the scaffold and the CAD design, the structures may need support 






 Inkjet bioprinting is based on the usage of cell-laden bioink droplets which are 
generated and deposited to established pre-defined scaffold regions (Figure 1.2).  An 
advantage to droplet bioprinting is the ability to allow for concentration gradients of cells, 
materials or growth factors throughout the 3D scaffold by altering droplet densities or 
proportions (Nakamura, 2005). Current research is utilizing droplet bioprinting for 
“scaffold-free” print design which consists of depositing layers of concentrations of cells 
in a sacrificial scaffold mold.  
 
3D Plotting and Bioplotting 
This technology is an all-purpose rapid prototyping printer that is capable of 
transforming an assortment of biomaterials using biofabrication from CATE.  Being very 
similar to FDM, a nozzle is used to extrude the melted material into the form of filament 
which solidifies on the cooled print bed.  A well-built bioplotter system can fabricate or 
Biofabricate scaffolds using an extensive spectrum of materials, ranging from hydrogels, 
polymers and hard ceramics and metals.  In the biofabrication process, 3D bioplotting 
has the capability for the design to incorporate multiple cell types into the structure 
during the printing phase of the complete process. 
 
Bioink Selection for Tissue Scaffold  
The extracellular matrix is the backbone to tissue regeneration for cell 
proliferation, adhesion and differentiation.  The ECM is generated either by the cells that 
are implanted exogenously or by the endogenous cells when they are exposed to 3D 
printed scaffolds (Newby et al., 2020).  Hence, the choice of the “bioinks” for a specific 
printer is an important factor in tissue engineering.   Bioinks constitutes the biomaterial 
(s) that is extruded by a printing nozzle or needle that generates a biofabricated matrix 
for cells while they produce the needed extracellular matrix for tissue regeneration.  
Alternatively, the ECM can be generated by blending natural or synthetic materials in 
vitro and used as a bioink.    Bioinks are characterized as structural, functional or 




the needed cell forces allowing for signaling pathways leading to cell survival and tissue 
development (Dussoyer et al., 2000).  The development of these materials needs to be 
studied in a step-by-step process for purification, material modification and the most 
challenging sterilization to be utilized in regenerative medicine applications. 
 
Acellular and Cellular Biofabrication 
Acellular scaffolds are those that typically mimic the biochemical and mechanical 
properties of the tissue ECM Scaffolds provide the environment for cellular attachment 
to stimulate tissue regenerative response.  Acellular bioprinting allows for a greater 
extent for material selection for biofabrication.  Acellular scaffolds must be bioresorbable 
and biocompatible and should demonstrate the potential to generate signals for 
biochemical, biomechanical and biophysical cues for cell migration and differentiation 
(Hutmacher, 2000).  Additionally, cellular scaffolds without any cellular component can 
be merely implanted into patients for structural and functional support in the 
regenerative process. 
 The biofabrication of a 3D cellular construct implements living cells in the design 
procedure.  Assorted emulsions have been developed to generate a 3D matrix of living 
tissue with each iteration having different strengths and limitations.  Bioinks 
incorporating cells have additional requirements, and thus, pose significant challenges.  
The printing process must preserve cell integrity and viability during resuspension and 
passage through the bioprinter nozzle and preparation of an environmental niche for cell 
growth and function within the printed biofabricated scaffold [Wust et al., 2011].  The 
deposition of the bioink depends on the printing mechanism. The representative 
techniques of cellular bioprinting can be categorized into three methods: extrusion-
based (pneumatic-, mechanical-, and solenoid-based), stereolithography and droplet-
based (Skardal, 2015). 
 
Tissue Engineering 
Different designs of scaffolds and printing as mentioned earlier greatly depend on 
the method of additive manufacturing process.  The ability to control degradation and 




exceptional biocompatibility both in vitro and in vivo are required in engineering 
experimental steps (Cancedda, 2007).  The biofabrication design of the scaffold should 
provide a three-dimensional support for tissue regeneration. This process should 
support cell proliferation leading to differentiation while promoting growth with 
surrounding vessels, resulting in an iteration with an end goal to replace the sustaining 
loads and functions of the flawed tissue.  The biofabricated construct should acquire a 
repository of biochemical and biophysical cues to promote precise response at the 
cellular level for tissue development. 
 
Cells for Biofabrication  
 The most abounding cell source in the body to support bioengineering is the 
MSCs.  MSCs may be isolated from adipose tissue and bone marrow and have 
capability for self-renewal and to differentiate into multiple cell linages in proper 
conditions in vitro and in vivo (Lee et.al., 2001).  Our focus in the use of cells in 
biofabrication centers on the use of adipose - and bone marrow - derived MSCs.  MSCs 
can also be classified as autologous and allogenic.  Autologous cells are transplanted 
from yourself, while allogenic cells are transplanted from a donor.  In human medicine, 
autologous stem cells have been used in medical treatment of injury and disease  
(Tobiat, 2011), while a number of clinical trials are ongoing to promote the use of 
allogenic cells (www.clinicaltrial.gov)  Combination of the cell’s ability for self-renewal 
and capacity to differentiate into chondrogenic, adipogenic, osteogenic and angiogenic 
lineages and a well-designed architecture construct plays an important role in the 
various stages for regeneration of tissue (Cherubino et al., 2011).    
 Various cell types have been printed using a 3D bioprinter. One of the 
impediments of engineering any scaffold is the ineffectiveness to biomimic the 
extracellular matrix of healthy tissue in the body when multiple cell types are integrated 
(Xu et al., 2013). With the ability to design a structured pattern providing an optimal 
environment for cells can prove to be very advantageous in regenerative medicine. 
Printers are adjustable, multitask, easily reprogrammed with a new CAD template and 
are provided with interchangeable stainless-steel blunt tip needles for injection to 




been placed on printing scaffolds which can serve as biomimetic components that can 
orchestrate tissue regeneration, provide tissue support, direct tissue regeneration and 
integration within a host tissue. As a result, some of the basic material elements that are 
considered during the printing process include percent porosity with ranging 
dimensions, internal geometric and projection modeling, biodegradation dynamics, 
mechanical properties, and cell biocompatibility. As a result, a lot of research and 
design is required to find an optimal material for a particular application (Guvendiren, 
2016).   
With the recent advances in cell-based therapies, 3D printing is becoming an 
increasingly common technique to generate scaffolds and medical devices for tissue 
engineering applications.  In the last decade, extensive research has been carried out 
towards developing biomaterials that are capable of mimicking the physiological and 
biological microenvironment of mesenchymal stem cells along with physicochemical 
properties that will control the cell behavior and fate.  Controlling cell behavior is one of 
the most important topics in regenerative medicine and is of particular interest to 
researchers by which the lessons can be transferred to the clinic with improved 
outcomes. Some of the factors that need special consideration in 3D printing of 
materials conducive for controlled cell behavior are highlighted below. 
 
Extracellular Matrix  
Remembering that the role the ECM plays is a critical position in providing 
structural support through ligands such as type I collagen and fibronectin which interact 
with MSCs in promoting remodeling (Salmasi et al., 2015).  During the tissue repair 
process the interaction between MSCs, native tissue cells, biofabricated construct and 
the ECM trigger cell signaling, release a variety of growth factors, and stimulate the 
healing process (Chen, 2016). 
A multitude of variables must be evaluated when designing constructs for stem 
cell responses to the simulated extracellular matrix compatibility.  Stimulus variables 
such as oxygen values, nutrient concentrations and mechanical cues stimulate cells to 
modify the secreted ECM to regulate the biological process including differentiation of 




natural construct, the ECM serves as an adhesive support not only for cells but the 
detachment of morphogens and growth factors that contribute to the maintenance of 
tissue function. The engineered ECM construct must incorporate the rigor and control of 
synthetic material manufacturing and favoring bioactivity to promote tissue remodeling 
at various levels.  The use of biomimetic regulated biodegradable materials can be 
engineered using a variety of biofabricated procedures such as 3D printing in an 
endeavor to mimic the biological cues of the natural ECM to incorporate the best 
mechanical and degradation profile. 
 
Extracellular Matrix-Material Interactions 
The physiochemical properties of base materials, whether synthetic or natural, 
must support cell viability during biofabrication, culture and degradation.  The 3D 
parameters of the constructs should not evoke cellular death, induce cell stress 
biomarkers or alter DNA makeup to cause a negative cellular change.  Many three-
dimensional fabricated porous constructs using single or mixed biomaterial types for in 
vitro and in vivo studies for cell-construct communications and tissue integrations have 
been used broadly to induce a tight cell matrix bond for tissue development.  These 
constructs are trying to clone the extracellular matrix and form a physical reinforcement 
to allow cellular migration, adhesion, proliferation which are required for tissue 
differentiation.  As the progression of material science and tissue physiology continues, 
the advancement of material biofabrication production to biomimic the ECM construct is 
required.  A precise value of porosity, cell to material surface area, safe chemical 
composition and a controlled degradation rate for a stronger end result (Yannas, 1989) 
are needed.  For the design of an effective ECM construct platform four properties have 
been laid out in the biofabrication process. First is the biodegradation rate as period of 
time, second is a biocompatible chemical cocktail to reduce cytotoxicity, third is the 
calculation of the microstructure taking in consideration the pore size, locations and 
geometrical orientation, and fourth the overall construct size for cell migration and 







 The primary objective for regenerative engineering is to optimize the 
biocompatibility of the 3D constructs supporting strong cell-tissue interactions.  Cell-to-
cell biochemical communication is indispensable to instigate initial attachment, while 
provoking ques for cell proliferation by the constructs surface texture and topography.  
These interactions give a clear interrelationship between the surface roughness of the 
biocompatible material and the tight relationship to adhesion, proliferation, and 
morphology of the cells (Linez-Bataillon, 2002).  Surface roughness of the biomaterial’s 
mixture plays a very important role in the expression of the ECM and cell adhesion 
proteins depending on the type of tissue that is being replaced by the 3D print (Grellier, 
2009, Linez-Batailion, 2002).  3D biofabrication progression to finite shapes and sizes 
for the ideal cell niche to promote adherence and growth has changed biomedical 
device engineering.  Printing constructs with high porosity and varying micrometer pore 
diameters with interconnective channels to increase cell to matrix surface area for cell 
attachment and tissue ingrowth are being generated.  Properties of the construct being 
physical, and chemical are also crucial in relation to the cell-matrix surface area 
interaction. Any variation in the 3D bioprinted structure factors can have a significant 
effect on cell adhesion, proliferation and differentiation in the tissue development in vitro 
and in vivo. 
  
Biofabrication Material Combinations 
 Ceramics, metals and polymers both natural and synthetic have been 
recommended in bone tissue biofabrication (Salgado, 2004).  Each material or mix of 
material has many pros and cons to being the perfect implantable medical device 
leading to desired shapes to mimic or having osteoinductive and osteoconductive 
properties or the perfect biodegradation rate for cell and tissue survival (Peppas, 1994).         
The process of biodegradability plays the greatest role in tissue regeneration if not 
controlled properly tissue may reproduce but may also struggle or die due to growth 
replacement rates.  The period of time a biomaterial remains insoluble in the body is 




the tissue must incorporate with the biofabricated construct to reinforce cell migration, 
adhesion, proliferation and fully support differentiation but the biofabricated material 
must biodegrade in a safe manner that will not interfere with the native tissue 
remodeling development.  Increasing density of the construct increases resistance to 
degradation but may also be achieved with increasing the crosslink density between the 
fibers (Yannas, 1989).  Crosslinking has an effect on cells and used in controlling 
natural and synthetic constructs.  Constructs of the natural blend are derived from 
sources such as fibrinogen, polysaccharides (chitosan, alginate, starch), proteins or 
collagen base.  Each of these biomaterials promotes and expedite cell attachment, 
migration through the design, differentiation and vascularization of tissue (Salago, 
2004).  Over the years natural constructs have been replaced with the use of synthetic 
biomaterials for bone tissue engineering (Nair,2006; Li et al., 2014). 
Various types of biodegradable synthetic polymers have widely been used to 
replace tissue damage at many organ levels.  Poly (glycolic acid) (PGA) causes 
inflammatory reactions to the surrounding tissue but has high tensile mechanical 
strength and stiffness with low solubility (Yamane, 2014). Modification of poly (ε-
caprolactone) (PCL) allows it to be highly compatible and has been examined as a 
material for controlled applications of various drug delivery models due to its low 
degradation rate of 2-3 years by microorganisms. 3D printing of a composite scaffold of 
PCL/hydroxyapatite (HA) with HA exposed onto the surface of scaffold for enhanced 
cellular response and osteochondral engineering. (Dwivedi et al.,2020; Idris et al., 
2010). Designing for excellent compatibility and bioabsorbability for the body is Poly 
(lactic acid) (PLA) as well as the PLA based copolymer poly (lactic-glycolic acid) (PLGA) 
which has been approved by the FDA for clinical use. The use of a nanocomposite with 
PLA has acceptable properties processing and mechanical support and as a result of its 
low degradation rate. It is extensively used as a fixative device in dental applications for 
bone fracture support, in medical devices for drug delivery, as well as possessing an 
outstanding biocompatibility, osteoinductive and osteoconductive properties for guiding 
biofabrication tissue regeneration (Zhang, 2015). PLA has four different variation’s that 




explored as an alternative to ceramic biomaterials (Chen,2003; Zhang 2015). Poly (LLA) 





orthopedic fixator device (Ulery, 2011).  It has been suggested that copolymers such as 
Poly (L-Lactide-co-caprolactone) {poly (LLA-co-CL)} copolymers are appropriate 
materials for enhancing cell differentiation for bone tissue repair (Idris,2010) These 
copolymers acquire acceptable mechanical properties, favorable biocompatibility and 
degradability that can be used to assemble constructs and increase behavior for cellular 
adhesion and proliferation (Nair, 2011).  
The synthetic constructs in material science biofabrication has allowed for 
designing in a variety of methods.  With pore architecture being so important the 
method of chemical/gas foaming came about.  This technique using high pressure 
carbon dioxide gas developed the method of continuous extrusion process for a high 
porous structure.  The saturation of the thermoplastic polymer mixes allowed designers 
to have precise pore distribution and size to achieve infiltration of cells in the construct 
with a suitable mechanical support (Mathieu, 2005).  Leaching of particles/salts, is 
solvent casting, which is a method that depends on totally on removal and complete 
evaporation of the solvent utilized.  This technique is a low-cost method with the 
fabrication not requiring a great deal of equipment.  Fabricating a multi-channel with 
high interconnectivity and porosity rate is completed by the method of freeze drying.  
The polymers are dissolved into a slurry and frozen then placed under very high 
vacuum, so the solvent is removed yielding a fabricated construct for tissue repair 
(Whang, 1995).  However, each of the techniques for fabrication has some 
disadvantages, such as the breakdown of the polymers using highly toxic solvents, 
limitations on structure design and mechanical properties, maintain added nanoparticles 
within the construct’s matrix, increased inconsistencies with pore sizes and shapes and 
yielding long processing times in the lab (Bose, 2013). 
To overcome these material design challenges the development of the various 
3D printing methods are being used to support a higher biocompatibility and less 




support formation of blood vessels within the matrix and use geometric shapes to form 
stronger mechanical supports to develop a functional replacement for bone or soft 
organ tissue engineering.  As the growth in regenerative medicine climbs the demand 
for 3D biofabrication is expected to increase exponentially.  The use of computer-aided 
tissue engineering technology to customize medical devices and to procedure 
constructs in a high reproducible manner with high quality control will improve the 
function of tissues with high mechanical properties, increased cell adhesion for 
proliferation and distribution in every surgeon’s operating room (Bose, 2013). 
Biofabrication – Summarizing Trends and Strategies 
With the significant progress made in all facets of biomedicine described in the 
above sections, there are many different options to approach a biofabrication project 
which can be successfully translated into the clinic (Gloria, 2010).  Based on the 
literature described above, this section summarizes the tools and the considerations 
that should be taken into account by researchers and clinicians for safe and efficacious 
cell-based therapies.  
1) Cell based therapy by taking tissue samples from the donor after breaking down to a 
cell platform and then seeding it directly to a tissue structure, supporting proliferation 
and differentiation, and promoting angiogenesis.  
2) A cell focus approach by using growth factor stimuli to develop a correlative 
regenerated tissue 
3) Design of a bioreactor as an internal or external device containing tissue. These are 
linked to the body to support or replace physiological functions, and  
4) Biofabricate a scaffold onto which tissue or mesenchymal stem cells are loaded and 
implanted to regenerate tissue.   
In order to achieve any of the above – mentioned method, the choice of the 
scaffold design is of prime importance. The scaffold design should be carefully chosen 
so as to allow a specific cell type to show in-growth and out- growth with the material so 
to restimulate the endogenous progenitor cells and regrow the damaged area of tissue 
by a cooperative action with the exogenous cells.  The scaffold can be designed from 




supporting cells via cell matrix-material interactions and biochemical release.  As 
described in the above sections, scaffolds can be acellular or cellular. An acellular 
design aids regeneration by angiogenesis, as vessels from the encompassing tissues 
attach or penetrate the scaffold layout.  This process allows the tissue to fill and modify 
the biofabricated scaffold, which over a period of time biodegrades and allows the tissue 
to sustain further growth supplied by the blood vessels.  Second, is a cellular design, 
where the patients stem cells, or an allogenic cell approach can be taken to seed the 
biofabricated design.  This method of scaffold design becomes intergraded and allows 
for expansion of the engineered tissue.  In order to be used in some form of tissue 
engineering the biofabricated scaffolds must meet the prerequisites summarized below 
(Causa, 2007; Gloria et al., 2013; Hutmacher, 2004). All the desired properties are 
interdependent and hence, in many instances, it is difficult to describe them as mutually 
exclusive, and hence, might result in some redundancy. 
 
Scaffold structure and design:  Regeneration of the human body is a very complex 
cascade of pathways, which have a very complex coordinated event of spatial and 
temporal modalities. Signal transduction is highly governed by biochemical cues which 
trigger the ECM microenvironment for development (Causa, 2007).  The biofabricated 
structure must provide a dimensional/porous balance so as to allow for cellular 
adhesion and proliferation controlling the expression of the extracellular matrix. The 
extracellular matrix provides a structural and dynamic communication between cells 
playing a very complex role in cellular fate, direct cell-ECM interactions, such as 
migration, adhesion and remodeling influence tissue development (Alford et al, 2015).  
Optimal porosity is one of the main features in the biofabricated design. Its primary 
responsibility as an interconnected labyrinth is for cell-to-cell communication, adhesion, 
diffusion and supportive network for vascularization as well as nutrients to cells and 
tissue and removal of cellular metabolic waste (Causa, 2007).  Degradation of the 
biomaterial can also affect pore dimensions and could potentially change the 
development of the tissue. 
As a result, the design layout should provide a three-dimensional space, so to 




stimulating tissue production, whilst gaining support from vasculature. The scaffold 
design should temporarily sustain tissue operations such as a load bearing support until 
the new bone is formed as expected in bone regeneration. 
 
Biocompatibility:  The biomaterial choice of the biomaterial is a key feature.  Natural or 
synthetic material selected for biofabrication must integrate and be compatible to the 
host and must have minimal to no host tissue inflammatory response.  If a response 
triggers an immunological cascade, the biomaterial must be non-cytotoxic, so that the 
biomaterial can modulate the tissue response (Hutmacher, 2000).  As a result, various 
concentrations of material mixes and solvents should be tested. The testing for cell 
viability or apoptotic activity represents a crucial marker in gene regulators for overall 
cellular apoptosis and can be performed in vitro prior to in vivo application. In summary, 
material design must support cell survival, with regulated biodegradation and resorption 
rates to mimic the structural tissue extracellular matrix, and proper mechanical 
properties to optimize the rate of tissue regeneration in vitro and in vivo (Butscher, 
2011; Hutmacher, 2000). 
 
Surface topography:  A 3D biofabricated construct is a template for cell adhesion, 
proliferation and differentiation to promote regeneration of a damaged or replaced tissue 
(Salgado, 2004; Müller, 2009).  Surface area for cell-matrix contact must be appropriate 
to support cellular nutrients and metabolic waste.  adhesion, migration and 
differentiation are key factors in a cellular process and one factor that can change the 
whole outcome is the substrate topography.  The integration between the biofabricated 
materials’ topographic patterns and cellular response can greatly improve the 
functionality and long-term stability of the scaffold implant. Topography of the scaffold 
can be used in a very effective manner to regulate cell adhesion migration and 
differentiation (Ventre, 2012). 
 
Degradation and restorability:  Biomaterial degradation are a very complex but 
important feature to consider when determining the biomaterial of choice and to be sure 




addition or subtraction of working groups on the material composition. It is important to 
understand the discordance between degradation and regeneration times which could 
lead to a problem during development.  If a degradation rate is too fast this can lead to a 
non-complete tissue development, while a slower degradation might result in incomplete 
regeneration. Ultimately, when the biomaterial degrades it should be easily processed 
and expelled without an inflammatory response within the host physiological system. 
 
Mechanical tradeoff:  Responsibility of the scaffold is to be a temporary replacement to 
support the damaged tissue and all functions, especially mechanical if dealing with 
osteo regeneration, while the new tissue is being regenerated.  Hence, understanding 
the connection between degradation of the scaffold and its mechanical properties is 
imperative. Understanding that there will be a transition where the regenerative tissues 
embrace a greater mechanical role as the scaffold degrades is of prime importance.   
 
Sterilization:  Another very challenging priority to scaffold properties is the requirement 
of having a sterile environment guaranteed for in vivo implantation and in vitro cell work.  
A crucial prerequisite to the design process is providing a sterile environment for cell 
growth plate ration and avoiding contamination. To that point the biomaterial of choice, 




One of the impediments of engineering any scaffold is the ineffectiveness to 
biomimic the extracellular matrix of healthy tissue in the body when multiple cell types 
are integrated (Xu et al., 2013). With the ability to design a structured pattern of cells in 
3D bioprinting, an optimal structure can be produced. 3D printing allows for several 
advantages in regenerative medicine. Printers are adjustable and can multitask; they 
can be easily reprogrammed with a new CAD template and interchangeable stainless-
steel blunt tip needles for injection to accommodate different biomaterials or cell types. 
3D bioprinting is an efficient process that can reduce the waiting time of the needed 




hence, has a huge potential in biomedicine. 3D bioprinting could facilitate fabrication of 





3D printing and bioprinting is versatile for tissue applications and has emerged as 
a new tool for biofabrication of constructs to create well-defined intricate and 
reproducible matrix architectures to replace human anatomy from disease.  The use of 
a 3D printed applications also allows for detailed reproducible iterations for a solid 
platform for in vitro models for studying geometrical architecture on various cellular 
feedback pathways, leading to enhanced mechanical production of bioengineered 
constructs.  With the use of CAD technology and integrations with medical software the 
allows for building of custom-made iterations based on each patient-specific tissue 
needs.  The needed understanding of chemistry and biology for material properties, 
CAD and slicers for software and the dynamics of the printer for hardware yields the 
interactions for the involvement of the printing process.  Therefore, choosing the correct 
processing conditions and the precise material properties facilitates in the reproduction 
of a high-quality 3D biofabrication.  Several biodegradable polymers such as PCL, 
PLGA, PLA, and PGA, and their copolymers have been used to Biofabricate 3D printed 
iterations (Chen, 2013). The preference of using a synthetic polymer and their 
copolymer materials is ease in processing into tissue biofabricated constructs and 
extreme versatility, which allow characteristic tailoring of biocompatibility, and the ability 
to vary biodegradation time, vary softness with solvents, wettability, mechanical strength 
(Li, 2014).   Utilization of 3D bioprinted bioinks and hydrogels for soft tissues including 
skin, liver, and vasculature have been demonstrated to create in-vitro models for 
bioreactor studies and drug testing applications, which is closer to reality than 3D 
bioprinted tissues for organ transplantation. Over the past years, many new exciting 
developments in the bioprinting field has been enabled by the development of bioinks 




bioink development will remain the key highlights of the future models in 3D bioprinting 
for tissue engineering. 
 3D bioprinted constructs and bioinks/hydrogels utilized should empower three 
main objectives; First, being define a space that sculpts the regenerating tissue, 
Second, maintain a temporary matrix to allow for tissue functions and Third, permit a 
model for tissue ingrowth support (Billiet et al., 2012).  The ideal biomaterial should 
mimic ECM properties and support cellular activity with interconnectivity for waste and 
nutrient flow without leading to cell functional damage and to maintain mechanical 
stability as biodegradation progresses to allow ECM from the cells inside the construct 
to gradually replace the lost biomaterial, this highlights the development of 3D 
printing/bioprinting/biofabrication for tissue engineering.   
In view of the challenges and the multifactorial nature of tissue engineering and 
regenerative medicine described in this chapter, it is very difficult to identify a strategy that can 
go from bench to bedside. As described in the next four chapters, I have used the information 
from our laboratory and the published reports to implement a bone tissue engineering strategy 
which could be used in a large animal preclinical model with a long-term goal of translating it 
into human medicine. This strategy consisted of generating in vitro models of human MSCs 
(Chapters 2, 3), identifications of the type and the form of the polymers and nanoparticles, and 
3D biofabrication of the scaffold (Chapter 4), and ultimately evaluation of the 
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Figure 1.1. Interrelation between Biofabrication, Additive Manufacturing and the Tissue 
Engineering and Regenerative Medicine fields.  
  
Biofabrication 














Figure 1.2 Schematic Illustration of Inkjet printing on the left and pneumatic extrusion 
























FUNCTIONALIZED GRAPHENE NANOPARTICLES INDUCE HUMAN 
MESENCHYMAL STEM CELLS TO EXPRESS DISTINCT 
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Purpose: The extracellular matrix (ECM) labyrinthine network secreted by 
mesenchymal stem cells, provides a microenvironment to enhance cell adherence, 
proliferation, viability, and differentiation. The potential of graphene-based 
nanomaterials to mimic tissue –specific ECM has been recognized in designing bone 
tissue engineering scaffolds. In this study, we investigated the expression of specific 
ECM proteins when human fat derived adult MSCs adhered and underwent osteogenic 
differentiation in presence of functionalized graphene nanoparticles. 
Methods: Graphene nanoparticles with 6-10% oxygen content were prepared and 
characterized by XPS, FTIR, AFM and Raman spectroscopy. Calcein-am and crystal 
violet staining were performed to evaluate viability and proliferation of human fat – 
derived MSCs on graphene nanoparticles. Alizarin red staining and quantitation was 
used to determine the effect of graphene nanoparticles on osteogenic differentiation. 
Finally, immunofluorescence assays were used to investigate the expression of ECM 
proteins during cell adhesion and osteogenic differentiation.  
Results: Our data shows that in presence of graphene, MSCs express specific integrin 
heterodimers, and exhibit a distinct pattern of the corresponding bone - ECM proteins, 
primarily fibronectin, collagen I and vitronectin. Furthermore, MSCs undergo osteogenic 
differentiation spontaneously without any chemical induction, suggesting that the 
physicochemical properties of graphene nanoparticles might trigger the expression of 
bone-specific ECM. 
Conclusion: Understanding the cell-graphene interactions resulting in an osteogenic 
niche for MSCs will significantly improve the application of graphene nanoparticles in 
bone repair and regeneration. 
Keywords: Graphene nanoparticles; functionalized graphene, human mesenchymal 










Bone tissue engineering scaffolds designed to utilize cell therapies function as 
delivery vehicles for osteoprogenitor cells and display their ability to attenuate the 
biological function of cells capable of osteogenic differentiation. Biomimetic scaffolds 
are dynamic, and their function is dependent on the interactions between the 
biomaterial and the cells (Sanz-Herrera and Reina-Romo 2011). These cells can be 
endogenous and be recruited from the tissues in which the scaffold is implanted, or 
exogenous cells delivered to the site of injury. Cell adhesion to the scaffolds triggers 
signals that can ultimately affect bone cell formation, referred to as osteogenic 
differentiation. 
Adult mesenchymal stem cells have emerged as a therapeutic modality in 
various realms of regenerative medicine and are the preferred cells for bone-tissue 
engineering. Compared to embryonic or induced pluripotent stem cells, the use of adult 
MSCs avoids ethical concerns and the cells can be obtained relatively easily from a 
variety of adult tissues. MSCs are typically isolated from bone marrow but can also be 
isolated from whole blood, umbilical cord blood, dental pulp, skin and adipose tissue. 
MSCs are spindle shaped, adherent, fibroblast-like cells that can be expanded in tissue 
culture to generate primary cultures (Caplan 2007, Bieback, Kern et al. 2008). Tissue 
culture expanded MSCs are a heterogenous population of cells, a subset of which have 
the potential to differentiate into osteoblasts (bone forming cells), in vitro and in vivo, 
when placed in an osteogenic environment. Hence, MSCs are a reliable and preferred 
source of osteoprogenitors (Pittenger, Mackay et al. 1999, Dominici, Le Blanc et al. 
2006).  
The progression of cells into an osteogenic lineage is regulated by the differential 
expression of osteoblast-associated transcription factors (Runt-related transcription 
factor 2; Runx2), adhesion molecules (integrins β1/ITGB1), and extracellular matrix 
(ECM) proteins (fibronectin, collagen I) (Daley, Peters et al. 2008, Frantz, Stewart et al. 
2010, He, Jiang et al. 2013, Wan, Lu et al. 2013). During osteogenic differentiation, cells 
initiate the synthesis of ECM, and express osteocyte-specific markers such as alkaline 




bone cell development. ECM is the non-cellular component present within all tissues 
and organs, providing structural support, promoting cell migration and adhesion, and 
triggering cell differentiation.  ECM is tissue-specific in its composition and topology and 
determines the “tissue – specific” niche. For instance, bone ECM consists of a specific 
and unique organization of collagen I fibers and hydroxyapatite (Alford, Kozloff et al. 
2015). Collagen I makes up more than 90% of the organic phase of bone, and the 
remaining 10% consists of proteins including fibronectin, laminin and vitronectin. 
Fibronectin, the major non-collagenous ECM protein, is ubiquitously expressed and 
contributes to the construction and organization of the ECM, having a significant role in 
cell adhesion and differentiation.  Vitronectin works with fibronectin to promote cell 
adhesion and proliferation at early stages of the cell–material interaction processes 
(Felgueiras, Evans et al. 2015). Vinculin is a component of focal adhesions has a major 
role in both the cell-to-cell and cell-to-matrix adhesion physiology.  Vinculin also plays 
an important role in the control of binding of actin filaments in cell adhesion to the matrix 
(Bays and DeMali 2017).  
Since ECM is tissue – specific, in bone tissue engineering particular attention has 
recently been given to the study of bone-specific ECM (structure, topography and 
biological composition). Hence, interest has shifted from inert biomaterials to constructs 
that are biomimetic with the native bone ECM (Curry, Pensa et al. 2016). These 
constructs can be generated either by adding MSCs (osteoprogenitors), specific growth 
factors (VEGF, PDGF etc.), coating bone - specific ECM proteins such as fibronectin 
and vitronectin (Mistry and Mikos 2005, Khademhosseini, Vacanti et al. 2009, Kundu, 
Khatiwala et al. 2009)onto the surface of scaffolds, or by using inherently bioactive 
scaffolds alone with physicochemical properties to match the native ECM.  The use of 
specific growth factors can be expensive and using protein coatings alone does not 
result in a composition, function, microstructure, and architecture that is sufficiently 
similar to native ECM. Therefore, the long-term goal of bone tissue engineering is to 
develop scaffolds that can create an “osteogenic” or “bone –specific niche” for cells by 
inducing the expression of bone - specific ECM proteins. 
Despite the lack of knowledge on the in vivo function of MSCs, it is widely 




(Nombela-Arrieta, Ritz et al. 2011). As such, MSCs are the preferred choice for use in 
bone tissue engineering. When MSCs are implanted in vivo, their survival, proliferation, 
differentiation and fate are dependent on the microenvironment or “niche” in which they 
are placed.  Cell fate is dictated not only by the ECM of the environment, but also by the 
response of the MSCs to the environment. When exogenous MSCs interact with 
biomimetic scaffolds, they can trigger the endogenous cells to produce ECM, or the 
MSCs themselves can express ECM proteins to form the matrix (Daley, Peters et al. 
2008, Frantz, Stewart et al. 2010, Assis-Ribas, Forni et al. 2018, Carvalho, Silva et al. 
2019) .  Thus, understanding the niche signals that are triggered, e.g., evaluating the 
ECM that is generated when MSCs are implanted in a bone defect will help the 
consistency and efficacy of bone tissue engineering and regenerative medicine 
approaches (Gattazzo, Urciuolo et al. 2014). 
Biomaterials for bone tissue engineering should be biocompatible, 
biodegradable, and bioactive as determined by their ability to be osteoinductive, 
osteoconductive, and be osseointegrated in vivo. Biomaterials fabricated into nanoscale 
(1-100 nm) structures (nanomaterials) have been shown to mimic the native ECM and 
thus, promote cell adhesion and osteogenic differentiation. Nanomaterials have been 
shown to have increased bioactivity for bone regeneration compared to their micron-
sized counterparts and hence, warrant study as new types of biomaterials potentially 
useful for bone repair (Zhang, Li et al. 2011, Grattoni, Tasciotti et al. 2012, Nosouhian, 
Razavi et al. 2015). The use of nanomaterials as scaffolds has the potential to enhance 
the mechanical stability, biocompatibility, and cellular survival of implanted constructs. 
Graphene-based nanomaterials have recently been recognized as useful components 
of bone tissue engineering scaffolds. Graphene derivatives are preferred over the 
pristine form and can be produced relatively easily by functionalization of pristine 
graphene, with the ultimate goal of reducing pristine graphene’s toxicity and increasing 
its usability in biomedical applications (Dubey, Bentini et al. 2015, Majeed, Bourdo et al. 
2017). Graphene derivatives, including nano-sheets, ribbons, and low/high/partially 
oxidized graphene, graphene oxide and reduced graphene oxide have varying physical 
and chemical properties and minimal to no toxicity. (Mao, Laurent et al. 2013) These 




specifically for bone tissue engineering (Zhang, Wang et al. 2016, Zhang, Wei et al. 
2016). Therefore, despite the concerns due to toxicity, graphene-based nanomaterials 
and scaffolds have been used successfully in bone tissue engineering (Dervishi, Li et al. 
2009, Mahmood, Casciano et al. 2010, Nayak, Jian et al. 2010, Nayak, Andersen et al. 
2011, Wang, Ruan et al. 2011, Mahmood M. 2013, Elkhenany, Amelse et al. 2015, 
Jeong, Choi et al. 2016, Majeed, Bourdo et al. 2016, Bourdo, Al Faouri et al. 2017, 
Elkhenany, Bourdo et al. 2017).    
Our laboratory has demonstrated that a low oxygen (6-10%) functionalized form 
of graphene nanocomposite (LOG – low oxygen graphene) is cytocompatible and 
exhibits osteoinductive effects in vitro and osteoconductive effects in vivo when used 
with fat-derived goat MSCs (Elkhenany, Amelse et al. 2015, Elkhenany, Bourdo et al. 
2017).  The aim of the current study was to evaluate the effect of low oxygen graphene 
nanoparticles on cellular adhesion and osteogenic differentiation of human adipose 
tissue derived MSCs (hMSCs), with a focus on the spatiotemporal expression profiles of 
ECM proteins during these processes. Our long-term goal is to evaluate the signaling 
mechanism(s) that are initiated when hMSCs are seeded on graphene nanoparticles, 
and the current study is the first step in that direction. We hypothesized that the 
structure and topographical features of functionalized graphene nanoparticles will create 
an “osteogenic niche” for human MSCs, which will be demonstrated by an attenuation of 





Isolation, ex vivo Expansion, and Characterization of Human MSCs 
Stromal vascular fraction cells were obtained from human adipose tissue from 
patients undergoing panniculectomies in accordance with a protocol approved by the 
IRB at the University of Tennessee Medical Center, Knoxville. The hMSCs were 
isolated, ex vivo expanded and characterized as described previously (Alghazali, 




through 6 only, and were incubated in complete growth media (DMEM/F12, 1% 
penicillin-streptomycin/amphotericin B, 10% FBS).   
MSCs obtained were confirmed by their morphology, potential to undergo tri-
lineage differentiation, and expression of specific protein markers, using methods 
reported previously (Dominici, Le Blanc et al. 2006, Alghazali, Newby et al. 2017). In 
vitro experiments were carried out simultaneously on control (polystyrene or plastic) and 
graphitic surfaces. The control substrates were chosen as appropriate for the assays 
under experimentation. 
In addition to the basic characterization of hMSCs, the expression of specific 
integrin heterodimers on their cell surface was evaluated in expanded cells. 1 × 106 of 
hMSCs were stained with anti-human α2β1, α5β1and αVβ6 (Millipore Sigma), α9β1 and 
αVβ3 (BioLegend), and αVβ5 (Developmental Studies Hybridoma Bank – University of 
Iowa), and their corresponding isotype matched controls. The manufacturer’s 
recommended concentrations of antibodies were used. For immunophenotyping, cells 
were harvested and counted, blocked in 1% goat serum in PBS for 20 minutes at room 
temperature, then stained with each primary antibody for 20 minutes at room 
temperature in the dark. Subsequently, cells were washed with PBS, collected by 
centrifugation and then incubated with either IgG1/APC or IgG2b/PE (Biolegend) 
secondary antibodies for 20 minutes at room temperature in the dark. Finally, cells were 
fixed with 4% paraformaldehyde/PBS for 10 minutes at room temperature in the dark. 
Roughly 20,000 events from each staining were analyzed using a BD FACS Calibur. 
The raw data was analyzed by FlowJo software. 
 
Preparation and Characterization of Functionalized Graphene Films 
Pristine graphene was modified to produce a low-oxygen functionalized form of 
graphene (LOG) with 6 to 10% oxygen content as reported previously (Elkhenany, 
Bourdo et al. 2017, Majeed, Bourdo et al. 2017). Briefly, graphene nanoplatelets 
(Product # N002-PDR, 1-1.2nm thick, ≤10µm lateral dimensions) were purchased from 
Angstron Materials (Dayton, OH) and subjected to an aqueous acidic environment (conc 




For coating a surface, a 15 mg mass sample of LOG was mixed with 30 mL of 
90% ethanol (200 proof, ACS reagent grade, Acros) /10%ultrapure water (18.2Mohm, 
0.055uS/cm). The mixture was bath sonicated for 60 min followed by probe sonication 
(Sonics Vibra-cell VCX-130 equipped with 6 mm probe tip, 100% power for 60 min in 
pulses of 5sec ON, 5sec OFF). The dispersed material was then dropped using a 
micropipette onto individual 15 mm plastic coverslips or in each well of a 12 well plate, 
to give a coating of 0.21mg/cm2. 
The physico-chemical nature of the LOG nanoparticles was confirmed by X-ray 
photoelectron spectroscopy (XPS), structural analysis by Raman spectroscopy, 
functional group analysis by infrared (FTIR) spectroscopy, and the surface roughness 
after coating of substrates was evaluated using atomic force microscopy (AFM).  XPS, 
Raman, and FTIR analyses were carried out as described previously (Bourdo, Al Faouri 
et al. 2017, Majeed, Bourdo et al. 2017).  Briefly, XPS was performed on powder 
samples placed on double-sided tape on a glass substrate, and their elemental 
composition was studied using a Thermo K-alpha (Waltham, MA) XPS. IR was 
performed on pressed pellets made from LOG powder sample and KBr using a Thermo 
Scientific FTIR Nicolet Model 6700 Spectrometer (Waltham, MA). Raman 
measurements were performed on samples of graphene powders placed on a silicon 
substrate using a 514 nm laser with Horiba Jobin Yvon LabRam 800 Micro-Raman 
(Edison, NJ). For AFM, the scans were obtained using tapping mode (3.90 V) at 0.5 Hz 
and 256 lines, with integral gains between 0.5 and 2.5 and amplitude setpoint averaging 
around 19 nm. Three different 50µm x 50µm randomly selected regions (edge, middle, 
and the center) were selected. The scans were then analyzed for surface 
roughness using NanoScope Analysis 1.5 (Bruker) software. Each surface scan was 
analyzed with the selection command across at least two dimensions to determine 
average roughness, Ra and root mean square, Rq.    
 
In vitro Cell Viability and Proliferation on LOG Nanoparticles 
Cell viability and proliferation of hMSCs on LOG was evaluated using two 




and crystal violet staining and quantitation were used, as described previously 
(Feoktistova, Geserick et al. 2016, Austin Bow 2019). 
Cell viability on LOG was assessed using calcein-am staining as per the 
manufacturer’s recommendations.  Briefly, 25X103 / cm2 hMSCs were seeded on LOG 
and control substrates and were incubated with a 2µg/mL calcein-am/dimethyl sulfoxide 
mix in HBSS at 370 for 5 minutes at 2, 4, 6 and 8 days post seeding. Green, fluorescent 
staining was visualized and imaged using All-in-one Microscope BZ-X700 (Keyence).  
Crystal violet staining and quantitation was used to determine changes in cell 
mass reflecting cell viability (Feoktistova, Geserick et al. 2016).  For staining, at 2-, 4-, 
6- and 8-days post-seeding, cells were fixed for 10 min with 4% paraformaldehyde/PBS. 
The fixed cells were stained with a 0.1% crystal violet solution in deionized water for 30 
min at room temperature then washed three times with deionized water. Crystal violet-
stained cells were visualized and imaged using All-in-one Microscope BZ-X700 
(Keyence).  For quantitation, the stain was dissolved in 10% acetic acid and quantified 
by measuring the absorbance at 595 nm (Synergy HT). Data was plotted and statistics 
performed in Prism (Graphpad). 
 
Osteogenic Differentiation and Mineralization 
For osteogenic differentiation, hMSCs at a seeding density of 25X103 cells/cm2 
were induced to undergo differentiation by exposing to complete growth media 
supplemented with 100nM dexamethasone, 10nM β-glycerophosphate and 155µM 
ascorbic acid. At 21 days, cells were fixed in 4% paraformaldehyde/PBS for 10 minutes 
at room temperature and stained with alizarin red to detect calcium in the osteoblasts. 
The accumulation of calcium in hMSCs was quantitated by the elution of alizarin red dye 
with 10% cetylpyridium chloride and the color was read at 570 nm (Elkhenany, Amelse 
et al. 2016).  Background readings due to the substrates alone without any cells were 
subtracted from the sample readings to eliminate nonspecific values. Data was plotted 







Cytoskeletal Organization and ECM Proteins  
Cytoskeletal organization and MSC morphology were assessed by evaluating the 
expression patterns of F-actin and vimentin using previously reported methods 
(Alghazali, Newby et al. 2017).  The expression of ECM proteins during cell attachment 
(i.e., within 24hrs of seeding) and osteogenic differentiation (21 days after seeding) was 
assessed qualitatively by immunofluorescence detection assays. A panel of ECM 
proteins including, two distinct fibronectin antibodies, 181 and 182, vitronectin, collagen 
I and II, laminin and vinculin were used. Briefly, hMSCs at specified time points were 
fixed with 4% paraformaldehyde at room temperature for 10 minutes, permeabilized 
with 0.1% Triton X-100 in HBSS at room temperature for 10 minutes, and subsequently 
blocked with the Universal Blocking Reagent (BioGenex) for 30 minutes at room 
temperature.  Cells were incubated with 1-2ug of all primary antibodies and samples 
were incubated at 4°C for 24 hours.  Alexa Fluor 594 phalloidin (A12381; Invitrogen), 
Vimentin (#550513; BD Pharmingen), Collagen I (#ab3470; Abcam), Collagen II 
(#ab34712; Abcam), Fibronectin 181 (MAB19172; R&D Systems), Fibronectin 182 
(#MAB19182; R&D Systems), Vinculin (#ab129002; Abcam), Vitronectin (#ab113700; 
Abcam), and Laminin (#MAB2144; R&D Systems). The cells were washed and 
incubated with appropriate Alexa Fluor – labelled secondary anti-mouse or anti-rabbit 
antibodies at room temperature for 30 minutes in dark. Alexa Fluor 594 Phalloidin was 
preconjugated and hence, did not require any secondary antibody treatment step. The 
cells were washed twice and mounted on microscope slides with a drop of Prolong Gold 
antifade reagent with 4′, 6-diamidino-2-phenylindole (DAPI; Molecular Probes by Life 













Pristine Graphene was Functionalized to Produce LOG Nanoparticles 
Pristine graphene was functionalized to improve dispersibility, and a form 
containing 6 to 10% oxygen was synthesized. This is referred to as low-oxygen 
graphene (LOG). The LOG nanoparticles used in these experiments are distinct from 
commercially available graphene oxide and reduced graphene oxide forms and have 
been extensively characterized and distinguished from the other forms, as described 
previously (Bourdo, Al Faouri et al. 2017, Majeed, Bourdo et al. 2017, Nima, Vang et al. 
2019).  The functionalized form of graphene was characterized by a variety of 
physicochemical techniques.  The XPS spectrum shows distinct photoemission peaks 
corresponding to C1s at 284.8eV, O1s at 533eV, N1s at 405eV, S2p at 164eV, with an 
average elemental composition of 88.73% carbon, 10.57% oxygen, and <0.5% of 
nitrogen and sulfur (remaining from reagents used during the oxidation procedure); 
thus, confirming that the synthesized form of graphene nanoparticles are indeed LOG. 
Further details from the XPS spectrum demonstrate the types of functional groups 
present in the samples. Both carbon (C1s) and oxygen (O1s) narrow scan spectra were 
collected and analyzed. After fitting analysis, the C1s narrow scan exhibited peaks at 
248.78eV (aliphatic/aromatic C), 286.14eV (C-O), 287.26eV (C=O), 288.83eV (carboxyl, 
O-C=O), and 290.70 eV for −* shakeup satellite peak. For the oxygen scan (O1s), 2 
main underlying peaks are present at 532.06eV for O-C and 533.69eV for O=C 
(Datsyuk V 2008, Yang D 2009). This data suggests a predominantly carbon – rich 
sample with hydroxyl, carbonyl, and carboxyl functional groups on the surface. 
In addition to XPS, Raman and infrared spectroscopy were used to characterize 
the graphene material. Raman spectroscopy provides information on the lattice 
structure of the materials and is displayed in Figure1D. The main spectral features are 
observed at approximately 1350 cm-1, 1600 cm-1, and 2700 cm-1 corresponding to the 
D-, G-, and 2D-bands, respectively (Malard, Pimenta et al. 2009). By analyzing the 
intensity of the D- and G-bands, the defect nature of the material was determined. The 
nanoparticles generated in this study displayed an ID/IG ratio of 1.34, which is consistent 




shown in Figure 1E provided evidence of oxygen functional groups, such as hydroxyl 
groups by stretching mode at ~3400cm-1 and bending mode at ~1400cm-1.  Carbon-
hydrogen and C-OH stretches are seen in the 2950–2850 cm-1 region and in the 1200–
1050 cm-1region, respectively. Carbonyl stretching mode was present at ~1720cm-1, 
with sp2 stretching from the extensive hexagonal carbon framework observed at 1630 
cm-1(Wojtoniszak, Chen et al. 2012). These vibrational modes observed in FTIR, 
coupled with results from Raman and XPS confirm that the synthesized form of 
graphene nanoparticles are indeed LOG as described previously (Bourdo, Al Faouri et 
al. 2017, Majeed, Bourdo et al. 2017, Nima, Vang et al. 2019). 
 
LOG Nanoparticles Exhibit Rough Surface  
Surface roughness was evaluated using atomic force microscopy.  AFM images 
show that the LOG surface had mean roughness values of ~630nm Rq (or RMS, root 
mean square) and ~460 nm Ra (average roughness), suggesting potential sites for cell 
attachment. 
 
Progenitor Cells are MSCs and Express Specific Integrin Heterodimers 
Fibroblast morphology and tri-lineage differentiation patterns of primary cultures 
generated from the human stromal vascular fraction confirm the MSC nature of cells as 
described previously (Alghazali, Newby et al. 2017). Of relevance to this study, the 
integrin heterodimer profile of MSCs was compared between tissue culture polystyrene 
substrate and LOG surfaces. Data shows that the expression pattern is conserved on 
both substrates. Specifically, there was a >90% expression of α2β1, αVβ5, α5β1 and 
α5β3 heterodimers on both surfaces, suggesting that the adhesion of hMSCs on the 
LOG surface is similar to that of the polystyrene surface and could be mediated via any 









LOG Surface is Cytocompatible 
Calcein – am staining and fluorescence imaging was used to confirm cell viability 
as well as distribution of hMSCs on LOG surface at specific time points (Figure 2.1a).  
Calcein – am is a fluorogenic, cell-permeant probe that indicates cellular health. Native 
Calcein-am is non-fluorescent and shows a green fluorescence only when it reacts with 
the esterase’s that are present within live, healthy cells. As a result, the green, 
fluorescent signal indicates cell viability. Additionally, data shows that hMSCs were 
healthy, viable and subjectively grew in population over a period of 8 days.  Cells 
showed a distinct pattern of adhesion and clustering on LOG surfaces relative to the 
random distribution observed on tissue culture polystyrene substrate. This pattern could 
be due to the clustering of cells to specific areas of LOG surfaces or that the graphene 
coating in those areas is too dark to image cells. In any case, the cells that are imaged 
appear healthy and hence, the LOG surface was deemed cytocompatible. 
Crystal violet staining (Figure 2.1b) and quantitation (Figure 2.1c) were used to 
evaluate cell proliferation. Data showed that cells adhered to LOG surface and 
proliferated with time and the cell numbers were comparable with tissue culture 
polystyrene substrate, further supporting the Calcein-am staining and confirming the 
cytocompatibility of LOG surfaces.   
 
LOG Nanoparticles Inherently Induce Osteogenic Differentiation 
In view of the data from our previously published study (Elkhenany, Amelse et al. 
2015, Elkhenany, Bourdo et al. 2017), osteogenic differentiation and mineralization of 
hMSCs on LOG surfaces was assessed using Alizarin red staining and quantitation 
(Figure 2.2).  Data shows that hMSCs seeded on LOG nanoparticles, demonstrated 
significantly greater calcium content relative to the cells on the control surface 
(p=0.0018). Interestingly, this upregulation was observed in the absence of any 
osteogenic inducing reagents (dexamethasone, beta-glycerophosphate or ascorbic 
acid), suggesting that the LOG surface induces accumulation of calcium in MSCs 
spontaneously, i.e., induces osteogenic differentiation in vitro. Calcium content was 
further enhanced (p=0.0088) in hMSCs on LOG when osteogenic inducers were added 




seeded on the control surface in the presence of the osteogenic inducers (p=0.05), 
suggesting a potential synergistic effect of LOG nanoparticles and the osteogenic 
inducing reagents. 
In order to study the osteoinductive effect of LOG nanoparticles without any 
interference from the osteogenic inducers, in vitro assays described below were carried 
out in the absence of osteogenic inducers and in growth media only. Correspondingly, 
to maintain the uniformity of the osteogenic status of the cells, hMSCs on the control 
substrates were differentiated in the growth media supplemented with the osteogenic 
inducers. 
 
Human MSCs Display Cytoskeletal Integrity on LOG Surfaces 
Cytoskeletal health and integrity of hMSCs was further confirmed on LOG 
surfaces by visualizing F actin filaments using a fluorescent derivative of Phalloidin.  
Fetal bovine serum in the cell media (growth and osteogenic media) is the main source 
of proteins that can adsorb onto a biomaterial and stimulate production of ECM. As a 
result, cytoskeletal integrity and morphology of hMSCs was evaluated in varying 
concentrations of FBS, ranging from 0% - 10%. Cells were fixed 24hrs post seeding and 
morphological evaluation of F-actin fluorescence showed that hMSCs on LOG in media 
containing 2, 5 and 10% FBS were relatively healthy and displayed robust cytoskeletal 
morphology. Cells in absence of FBS (0%) appeared rounded and unhealthy. Although 
cells survived the 2, 5 and 10% FBS media on LOG surface, corresponding cells on the 
control surface appeared unhealthy, were not viable and did not proliferate in media 
with <10% FBS (data not shown). In order to maintain identical cell culture conditions, 
hMSCs were seeded on both the control and LOG surfaces in media containing 10% 
FBS in all subsequent experiments. The cytoskeletal integrity of cells was first 
confirmed at 24hrs during cell adhesion e, and subsequently, during osteogenic 
differentiation at day 21.  
Simultaneous to the above experiments, we ensured that the stem cell nature of 
hMSCs was maintained throughout the study period by evaluating the expression of 
vimentin, a mesenchymal stem cell marker (Secunda, Vennila et al. 2015). Data 




that hMSCs did not lose their “stem cell” characteristics during the cell culture process 
on LOG surfaces.  
 
ECM Proteins are Expressed on LOG Surfaces 
In order to evaluate the expression of ECM proteins that might be contributed by the 
serum in the media, IF assays were carried out on LOG surface in the absence of cells 
and only in presence of 10% FBS-containing media at 24 hours and at day 21. The 
expression patterns of collagen I, collagen II, fibronectin, laminin, vinculin, and 
vitronectin were evaluated. IF analyses on the LOG surface did not show the expression 
of any ECM proteins in the absence of hMSCs in any of the samples tested, clearly 
demonstrating that the serum proteins do not contribute to the ECM on LOG surface 
and hence, do not have a role in cell adhesion or differentiation.   
Next, we evaluated the expression of ECM proteins when hMSCs were seeded 
on the LOG surface (Figure 2.3). The expression patterns were evaluated at 24hrs to 
assess the ECM proteins involved in cell adhesion and at day 21, to evaluate proteins 
involved in osteogenic differentiation. There was expression and a discrete pattern of 
distribution for collagen I, fibronectin 182, vinculin and vitronectin was evident within 
24hrs post-seeding. Collagen II was weakly expressed and there was no expression of 
laminin, suggesting that either these proteins are not involved in adhesion and 
osteogenic differentiation of hMSCs on the LOG surface, or that the specific antibodies 




In this study, we present in vitro data to show that in presence of functionalized 
graphene nanoparticles with 6-10% oxygen content, human fat-derived MSCs express 
and secrete a discrete and organized pattern of bone–specific ECM proteins within 
24hrs post seeding. This pattern persists throughout the osteogenic differentiation 
process through day 21.  Noteworthy is the fact that these ECM proteins were found 
only in the presence of hMSCs without any contribution from the FBS present in the 




calcium content accumulated in the cells, undergo osteogenic differentiation, suggesting 
that the interaction between integrin and the corresponding ECM proteins might mediate 
cell adhesion and subsequent osteogenic differentiation. Most importantly, in the 
presence of LOG substrates, hMSCs undergo osteogenesis spontaneously without any 
osteogenic inducers. These results prove our hypothesis that the surface chemistry and 
topography of LOG nanoparticles create an osteogenic niche for hMSCs, at least in part 
by inducing the expression of specific ECM proteins and thus, eliminating the need for 
osteogenic inducing agents.  
Graphene nanocomposites that are being developed for bone tissue engineering 
are intended to serve as ECM analogs, but little is known about the mechanisms by 
which they regulate cell function. It is possible that similar to gold nanoparticles, 
graphene nanoparticles may interact with the ECM to up-regulate β1-integrin, generate 
mechanical stress on the MSCs resulting in activation of the p38 MAPK pathway, and, 
in turn, may induce spontaneous osteogenic differentiation (Yi, Liu et al. 2010, Nayak, 
Andersen et al. 2011, Zhang, Lee et al. 2015). Furthermore, osteogenic inducers 
included in the growth media may create an osteogenic environment for MSCs to 
commit towards osteoblast lineage. The expression of specific ECM proteins by hMSCs 
on LOG surfaces potentially provides cues for cells to undergo osteogenic 
differentiation, the exact signaling mechanism(s) of which needs to be elucidated. 
One major challenge in bone tissue engineering is to develop novel scaffolds 
capable of controlling cell fate. This is the essence of biomimicry. Besides biochemical 
stimuli, physical properties of scaffolds including, surface patterns, elasticity and 
nanotopography have been shown to affect osteogenic differentiation of MSCs (Qian, 
Gong et al. 2017, Goriainov, Hulsart-Billstrom et al. 2018, Metavarayuth, 
Maturavongsadit et al. 2019). It is possible that the areas of cell clustering observed on 
LOG nanoparticles overlap with areas of increased surface roughness, and hence, 
provide an ideal niche for anchoring, proliferation, and potentially osteogenic 
differentiation and mineralization. Published research supports that rough surfaces 
allow cells to attach more easily due to the multiple sites for cell‒surface interaction and 
increasing cytoskeletal stresses result in recruitment of more adhesive molecules 




herein demonstrate that attenuation of osteogenesis may be partially due to the rough 
topography of LOG nanoparticles, further supported by published studies (Deng, Liu et 
al. 2015, Xu, Liu et al. 2015, Wang, Deng et al. 2016, Damiati, Eales et al. 2018, Zhang, 
Lin et al. 2018, Zhang, Chen et al. 2018).  
Detailed evaluation of F actin staining, and ECM protein expression profiles 
showed that hMSCs adhered, spread and covered the LOG surface within 24 hours.  
Distinct areas with filipodia extensions were observed, suggesting tight cell-material 
interactions.  Furthermore, cells arrange in multilayers, and form clusters with time, 
suggesting that the LOG surface offers some cell guidance, i.e., attachment is not 
random, but organized. Clustering of hMSCs, a hallmark of osteogenic differentiation 
(Jackson, Bow et al. 2018) further supports the commitment towards osteoblast lineage, 




Our data supports our hypothesis and confirms that the LOG nanoparticles used 
in these studies are cytocompatible, inductive of osteogenic differentiation and, that 
hMSCs recognize graphene nanoparticles as biomimetic in vitro substrates for the 
purpose of osteogenic cell culture experiments. These results are similar to that 
previously reported for goat MSCs (Elkhenany, Amelse et al. 2015, Elkhenany, Bourdo 
et al. 2017).  We demonstrate the expression of specific ECM proteins by hMSCs in 
response to a specific form of LOG graphene nanoparticles. The graphene 
nanoparticles + MSC constructs provide us with a system that can be used to 
understand the signaling mechanisms, or cues, that are triggered when MSCs are 
committed towards the osteogenic lineage. Future experiments using this system will 
potentially aid in exploring the mechanisms underlying osteogenesis mediated by the 
specific ECM proteins on LOG nanoparticles, which will further improve the applicability 
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Figure 2.1 (a) Cell viability staining. Cell viability was evaluated on tissue culture polystyrene (I) and low-oxygen graphene 
(LOG) (II) by calcein-am staining. Calcein-am exhibits green fluorescence and demonstrates live cells. Fluorescent 
images show that human mesenchymal stem cells (hMSCs) adhered to and were viable on LOG surfaces similar to tissue 
culture polystyrene at all -time points. A distinct clustering of cells was, however, observed on LOG surface as early as 2 
days post seeding and continued throughout the experiment on day 8. 
Scale bar =100um.
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(c)  
Figure 2.1 (b) Indirect staining (c) Crystal violet quantification. Further confirmed cell viability and proliferation when 
hMSCs adhered to tissue culture polystyrene (I) and LOG(II) surfaces using crystal violet staining between days 2–8. 
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Figure 2.2.  Osteogenic differentiation assay. Calcium content of cells that were seeded 
on tissue culture polystyrene (Control) and low-oxygen graphene (LOG) surfaces were 
visualized by Alizarin red staining and subsequently quantitated. The calcium content of 
cells seeded in growth media without any osteogenic inducers (undifferentiated) was 
compared to cells that were exposed to differentiation media (differentiated) for 21 days. 
Media blank, i.e., the tissue culture polystyrene and LOG surfaces without any cells 
were used as blanks and the corresponding absorbance readings were subtracted. 
Significantly different values (p<0.05) are indicated by letters. Identical letters indicate 


















Figure 2.3. Expression of ECM proteins. Proteins expressed during cell adhesion 
i.e., within 24hrs (A) and differentiation i.e., at day 21 (B) were assessed using IF 
assays. The insets show the expression of the same proteins on tissue culture 
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Mesenchymal stem cells (MSCs) can be isolated from any adult somatic tissue. 
Bone marrow and adipose tissue are the two common sources. Furthermore, the 
biological quality of the MSCs from both sources can vary with the donor.  A 
functionalized form of graphene containing 6-10% oxygen (referred to as low oxygen 
graphene, LOG, by our group) is distinct from graphene oxide but shares similar 
properties with the commercially available reduced graphene oxide (rGO). The effects 
of LOG and rGO can be utilized as a cell-adhesion construct and/or a possible 
transporter for growth factors to support osteogenic differentiation of MSCs.  
Understanding the graphene-cellular interaction is essential for considering graphene 
nanoparticles as a potential candidate for biofabricated applications. The 
biocompatibility of LOG and rGO surfaces were assessed subjectively by cell adhesion. 
Cell morphology was assessed with green fluorescent protein (GFP) transduced MSCs.  
Expression of ECM proteins by human adipose stem cells and human bone marrow 
mesenchymal stem cells (BMSCs) were evaluated by immunofluorescence. A panel of 
specific antibodies, including vimentin, fibronectin, F-Actin, collagen I, vinculin and 
vitronectin at multiple time points after seeding were used.  Cell adhesion plays a crucial 
part in facilitating cell fate and it is influenced by the cellular environment. This study 
suggests that a surface coated with LOG or rGO or incorporated into a scaffold will be 







 The extracellular matrix of tissue forms a physical microenvironment construct 
where cells reside and are cued to secret factors to support the surrounding 
environment.  This microenvironment niche allows for a dynamic biochemical and 
biophysical signaling to influence cells to complete many tasks for development, with 
these cells being stem cells (Gattazzo, 2014).  Stem cells express ECM molecules at 
the very earliest embryonic stages of development (Zagris, 2001). The ability to identify 
and isolate cells, from a variety of tissue sources from human or animal is of 
extraordinary significance. Cells can be expanded boundlessly in tissue culture, and 
under controlled conditions directed to differentiate into the appropriate cell type of 
importance. Tissue-derived adult stem cells, such as adipose, epithelial and bone 
marrow have limited potential for multi patient use due to histo-incompatibility driving a 
need for a compatible therapeutic cell source.  
Even though, bone marrow and adipose tissue derived MSCs exhibit similar cell 
properties, their efficacy however, i.e., their biological function in vivo can vary. This is 
primarily due to donor-to-donor variations. Furthermore, the cell-scaffolds’ interaction 
may vary as well. In summary, the performance and efficacy of MSCs is dependent on a 
multitude of factors (Figure 3.1).  Mesenchymal stem cells have the ability to 
differentiate into myocytes, osteocytes, chondrocytes and neurons in vitro and in vivo 
(Seong, 2010).  Biocompatibility of the construct is directly related in the adhesion, 
proliferation rate and viability of cells (Naujoks et al., 2011). Specific physiochemical 
properties of graphene-based constructs and the biocompatible is capable of aiding 













Adipose Tissue MSCs – Patient 3 
Human adipose tissue was isolated from patients undergoing panniculectomies 
in accordance with a protocol approved by the Institution Review Board at the University 
of Tennessee Medical Center. After resection, the adipose tissue was transported to the 
lab and immediately processed as previously described (Alghazali et al., 2017).  Briefly, 
the lipoaspirate was rinsed with phosphate buffered saline (PBS) and then minced into 
smaller pieces for efficient digestion. Tissue was enzymatically digested in 0.1% 
collagenase, 1% bovine serum albumin (BSA) and 2mM calcium chloride in PBS at 
37⁰C for 30-45 mins, with intermittent shaking until a homogenous solution was 
obtained. After digestion, the samples were centrifuged at 300xg for 5 minutes at room 
temperature then shaken to disrupt the pellet and centrifuged a second time (Figure 
3.2). The oil/fat and supernatant were removed, and the pellet of the stromal vascular 
fraction (SVF) was washed with PBS. The pellet was suspended in stromal medium 
(DMEM/F12, 1% penicillin-streptomycin/amphotericin B, 20% fetal bovine serum (FBS) 
and passed through a 100m cell strainer to remove undigested tissue. The single cell 
suspension was seeded in tissue culture flasks and incubated for 48 hours in a 
humidified 5% CO2 incubator at 37⁰C. The flasks were washed with PBS to remove 
loosely attached cells and fresh stromal media was added. The cells were grown to 80-
90% confluence and then harvested with 0.05% trypsin EDTA, for cryopreservation in 
80% FBS, 10% DMEM/F12, 10% DMSO or, split and seeded into new flasks for 
expansion. All experiments were performed using cells from passage 2-6 in complete 
growth media (DMEM/F12, 1% penicillin-streptomycin/amphotericin B, 10% FBS).  
Adipose tissue derived MSCs were characterized by flow-cytometric analysis for 
expression of MSC markers and their potential to undergo tri-lineage differentiation by in 
vitro adipogenesis, osteogenesis and chondrogenesis as described earlier (Dominici et 
al., 2006).   Differentiation was confirmed by Oil Red O staining of the lipid droplets, 






Bone Marrow MSCs  
 Human bone marrow mesenchymal stem cells were purchased from ATCC 
(Manassas, VA USA) at passage 1.  They were cultured in flasks using ATCC 
recommended protocol in an incubator with humidified atmosphere, 5% CO2, and 37oC.  
Cell culture was maintained until the flask reached 85-90% confluency.  Cells were then 
trypsinized (trypsin 0.05%, USA) and cultured for further passages following same 
protocol until passage 5. For this study passage 4 was used on all experiments. The 
commercially obtained BMSCs have been demonstrated by the vendor to express the 
stem cell markers and have been demonstrated to undergo in vitro trilineage 
differentiation. 
 
Alizarin Red Staining Calcium Content During Osteogenesis 
Patient 3 -ADMSCs and BMSCs were cultured to 80-85% confluency in growth 
media.  For experimental conditions, cells were harvested and seeded at 25x103 on 
LOG thin films as described in chapter 2.  Cells were cultured on LOG for 21 days and 
maintained in growth media without support from osteo-differentiation media.  At 21-day 
time points films were stained with Alizarin red. 
Alizarin Red allows for visualization of calcium production which is evaluated by 
staining the samples with alizarin red solution, which is a dye that binds to extracellular 
calcium salts.  The evaluation for calcium production was carried out comparing Patient 
2 from previous study in chapter 2 to Patient 3 and bone marrow cells on graphene for 
osteogenesis.  The accumulation of calcium in hMSCs was quantitated by the elution of 
alizarin red dye with 10% cetylpyridium chloride and the color was read at 570 nm 
(Newby et al., 2020).  Background readings due to the substrates alone without any 
cells were subtracted from the sample readings to eliminate nonspecific values. Data 
was plotted and statistics performed in Prism (Graphpad). 
 
Green Fluorescent Protein /Red Fluorescent Protein Transduction of MSCs 
Production of Lentivirus  
Modification of human adipose mesenchymal stem cells were cultured in the lab 




population of lentiviral (LV) victors expressing enhanced red fluorescent protein (RFP) 
and green fluorescent protein (GFP) were processed (Masi, unpublished).  Infected 
MSCs were cultured and passaged for future cell studies on biomaterials or constructs.   
 
Cytoskeletal Organization and ECM of Patient 3 and BMSCs Proteins on LOG and rGO  
Cytoskeletal organization and MSC morphology were assessed by evaluating the 
expression patterns of F-actin and vimentin using previously reported methods 
(Alghazali et al., 2017). The expression of ECM proteins during cell attachment (i.e., 
within 24hrs of seeding) and osteogenic differentiation (21 days after seeding) was 
assessed qualitatively by immunofluorescence detection assays. A panel of ECM 
proteins including, two distinct fibronectin antibodies 182, vitronectin, collagen I and II 
and vinculin were used. Briefly, hMSCs at specified time points were fixed with 4% 
paraformaldehyde at room temperature for 10 minutes, permeabilized with 0.1% Triton 
X-100 in HBSS at room temperature for 10 minutes, and subsequently blocked with the 
Universal Blocking Reagent (BioGenex) for 30 minutes at room temperature.  Cells 
were incubated with 1-2ug of all primary antibodies and samples were incubated at 4°C 
for 24 hours.  Alexa Fluor 594 phalloidin (A12381; Invitrogen), Vimentin (#550513; BD 
Pharmingen), Collagen I (#ab3470; Abcam), Collagen II (#ab34712; Abcam), 
Fibronectin 181 (MAB19172; R&D Systems), Fibronectin 182 (#MAB19182; R&D 
Systems), Vinculin (#ab129002; Abcam) and Vitronectin (#ab113700; Abcam).  The 
cells were washed and incubated with appropriate Alexa Fluor – labelled secondary 
anti-mouse or anti-rabbit antibodies at room temperature for 30 minutes in dark. Alexa 
Fluor 594 Phalloidin was preconjugated and hence, did not require any secondary 
antibody treatment step. The cells were washed twice and mounted on microscope 
slides with a drop of Prolong Gold antifade reagent with 4′, 6-diamidino-2-phenylindole 
(DAPI; Molecular Probes by Life Technologies). The cells were analyzed under a 








Preparation of Reduced Graphene Oxide Nanoparticle Thin Surfaces 
 Reduced graphene oxide was obtained commercially from Cheap Tubes Inc 
(Grafton, VT, USA). Graphite powder yields graphite oxide when synthesized by the 
Hummer’s method (Wu, 2010).   The reduction by thermal methods to synthesize GO 
yields rGO in achievement to minimize the number of oxygen groups attached (Pei, 
2012) (Figure 3.3).   
Reduced graphene oxide with a thickness of 0.7-1.2nm, Y&Y dimension at 300-
800nm, Purity of 99 wt.%, method by modified Hummer’s was used to generate 2D films 
for this study.  4mg of rGO was mixed with 2 mL of 95% EtOH and sonicated with an 
Ultrasonic unit for 1 hour keeping the water at 20-25oC.  The resulting dispersion is 
2mg/mL and 0.2mg/cm2 (i.e., 100l/cm2) was the desired surface amount for a 15mm 
coverslip receiving 150l.  Coverslips were then transferred to a vacuum oven with at 
50oC and -25 psi for 1 to 1.5 hours.  Coverslips were then taken for gas sterilization and 
stored in the dark until needed for experiments. 
 
Following methods were used to characterize rGO dispersions. These 
characterizations were carried out at the Center for Integrative Nanotechnology 
Sciences, University of Arkansas at Little Rock by Dr. Shawn Bourdo. 
X-ray Photoelectron Spectroscopy (XPS) and Raman Spectroscopy on rGO 
 The physico-chemical nature of the rGO nanoparticles was confirmed by X-ray 
photoelectron spectroscopy (XPS), structural analysis by Raman spectroscopy.  XPS is 
a qualitative and quantitative technique used to characterize surface chemical states for 
elemental composition and binding states of the synthesized materials.  An X-ray beam 
excites the atoms on the surface of the sample causing a release of photoelectrons.  
Synthesized rGO was prepared as films by aqueous dispersion on glass slides and 
dried prior to characterization.   
 The synthesized constructs were analyzed via Raman spectrum.  The chemical 
analysis is expressed by a number of peaks, displaying the intensity and wavelength 








Patient 3 Characterization 
Patient 3 MSCs were successfully isolated form adipose tissue. Flow-cytometric 
analysis was used to characterize specific cell surface markers.  Analysis showed that 
ADSCs expressed MSC markers CD29, CD44, CD73, CD90, and CD105 in all cells and 
were negative for hematopoietic markers CD34, CD45, HLA-DR and endothelial marker 
CD106 expression (Figure 3.4.). Tri-lineage differentiation potential was performed for 
each lineage by being supplemented by the proper induction media.  Adipogenic 
lineage confirmed oil droplets by staining Oil Red O, chondrogenic differentiation was 
confirmed by staining with Alcian blue and osteogenic differentiation was confirmed by 
Alizarin red.  (Figure 3.5) 
 
Alizarin Red in vitro Differentiation 
 Cells were cultured for 21 days on a graphene film coated 12 well plate.  When 
cultured for 21 days in presence of growth media a thin layer of mineralized tissue is 
represented on the graphene film.  Quantification of the alizarin red stain confirmed that 
patient 3 cells performed as well as patient 2 did in pervious graphene experiments. 
(Figure 3.6). Upregulation was observed in the absence of any osteogenic inducing 
reagents (dexamethasone, beta-glycerophosphate or ascorbic acid), suggesting that the 
LOG surface induces accumulation of calcium in MSCs spontaneously, i.e., induces 
osteogenic differentiation in vitro.  hBMSCs seed on LOG for 21 days expressed 
significantly greater calcium content relative to the cells on the control suggesting that 
the LOG surface induces accumulation of calcium in hBMSCs spontaneously without 
osteogenic inducers in vitro (Figure 3.7). 
 
Green Fluorescent Protein Transduction of MSCs 
 The adipose cells that were transduced were tested to see if they would be 
usable in future studies. The test showed cells performed well over multiple time points 
with no problems in proliferation morphology and reduction in fluorescence.  Images 




cells and can definitely be utilized in future studies for tracking proliferation and possible 
differentiation in biofabricated constructs.  
 
XPS and Raman Spectroscopy of rGO 
XPS spectrum at 3 sample spots of rGO were investigated and the average 
values showed elemental composition of 83.45%C, 12.48%O, and 4.07%N (Figures 
3.9 – 3.10). 
 Raman of the 3 sample spots showed the ratio of intensity of D/G bands that is a 
measure of the defects present on graphene the structure and particularly for 
distinguishing the disorder in the crystal structures of carbon (Figure 3.11). The G band 
arises from the stretching of the C–C sp2 bond in graphitic materials a result of in-plane 
vibrations of carbon atoms whereas the D band is due to out of plane vibrations 
attributed to the presence of structural defects and dangling sp2 carbon bonds that 
break the symmetry. 
  
Adipose tissue MSCs – Patient 3 Response to Graphene 
LOG 
 The analysis of ECM proteins by immunofluorescence we performed in chapter 2 
were repeated here using ADMSCs from patient 3 on LOG. The expression of ECM 
proteins evaluated at 24 hours and 21 days by using media only on LOG as a control. 
The expression patterns of collagen I, collagen II, fibronectin, vinculin, and vitronectin 
were evaluated. IF analyses on the LOG surface did not show the expression of any 
ECM proteins in the absence of hMSCs in any of the samples tested, clearly 
demonstrating that the serum proteins do not contribute to the ECM on LOG surface 
and hence, do not have a role in cell adhesion or differentiation.  The evaluated 
expression of ECM proteins when patient 3 MSCs were seed on LOG showed at 24 
hours to assess the ECM proteins involved in cell adhesion (Figure 3.12), and, at day 






Patient 3 ECM protein evaluated images on control and rGO.  No ECM protein 
expression of any ECM proteins in the absence of hMSCs in any of the samples tested, 
clearly demonstrating that the serum proteins do not contribute to the ECM on rGO 
surface and hence, do not have a role in cell adhesion or differentiation. Evaluation at 
24 hours of ECM proteins involved in cell adhesion (Figure 3.14) were expressed and 
at 21 days all ECM proteins were expressed (Figure 3.15) involved in osteogenic 
differentiation, showing that rGO could be utilized as a possible construct in future 
studies. 
Bone Marrow Cellular Response to Graphene 
LOG 
Bone marrow stem cells were seeded to LOG under the same conditions and 
time points 24 hours and 21 days were tested on the same ECM proteins.  At the 24-
hour time point proteins were evaluated vimentin was positive and showed signs of 
stress morphology, Fibronectin expression was evaluated but limited compared to 
adipose cells, F-Actin showed microtubule formation with vinculin confirming cell 
adhesion, Collagen I and vitronectin was expressed but defused.   21-day time point 
showed signs of proliferation and adhesion.  Vimentin showed a more defined 
morphology, fibronectin was expressed but again limited as to adipose cells, F-Actin 
and vinculin were expressed showing morphology and adhesion to the rGO film, 
Collagen I expression was increased and vitronectin showing cell adhesion and 
migration also increased (Figure 3.16). 
 
rGO 
 Bone marrow cell expression showed remarkably different results on rGO.  At the 
24-hour time point vimentin showed bipolar morphology, fibronectin had increased 
showing tight communication or aggregation of the cells.  Evaluation of F-Actin showed 
high cell communication and microtubule response and was confirmed by vinculin, 
Collagen I expression was abundant and vitronectin confirmed adhesion.   Evaluation at 




pattern described as a brush stroke in a circular formation.  The patterns by each 
protein expressed formed a tighter cell-cell and cell-matrix showing cell communication 





We reported the comparative osteogenic capabilities of ADMSCs and BMSCs on 
LOG and rGO films.  The properties of graphene nanoparticles such as sizable surface 
area, ability to aid in mechanical properties and utility to blend with other synthetic or 
natural substrates allows for multiple material constructs to be used in cell research.  
This study showed that two derivatives of graphene nanoparticles are biocompatible, 
allowing for cell viability, adhesion, proliferation and support to stem cells into 
osteogenic lineage identified by ECM proteins. Adipose stem cell ECM proteins 
expressed immunofluorescence on both derivatives.  Observation of these cells showed 
increased ECM protein synthesis indicating cell-matrix adhesion to the film surface.  
Observation of bone marrow stem cells on LOG showing cell morphology at both time 
points became smaller and more stressed at 24 hours than 21 day which may be a 
result of oxidative stress that must be further evaluated.  Observations of cultured bone 
marrow cells of rGO exhibited distinctly stronger capability of ECM protein expression at 
24 hour and 21-day time points. Comparability of graphene nanoparticle in modified 
forms blended with natural or synthetic biomaterials for biofabricated implants must be 
performed to achieve the regenerative support of graphene.  A in vivo animal study will 
allow for the study of biodistribution of the nanoparticles and gain knowledge of a 
cellular metabolic pathways that can be used to engineer future tissue biofabricated 
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Figure 3.2. Patient 3. Isolation of collected adipose-derived mesenchymal stem cells 













   
                 
 Figure 3.3. Methods for obtaining reduced Graphene Oxide. Image source from  
    Graphene-info.com 
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Figure 3.4. Immunophenotyping of hMSCs by flow cytometry.  Human MSCs were stained with the indicated antibodies 
and then analyzed for expression by flow cytometry.  MSCs all strongly express markers associated with the 
mesenchymal stem cells (CD29, CD44, CD73, CD90, CD105), while expression of hematopoietic (CD34, CD45, HLA-DR) 
and endothelial (CD106) markers are negative.  Colored open histograms represent reactivity with the indicated 
antibodies; black open histograms indicate isotype matched controls for each antibody. 







































Figure 3.5. Tri-lineage differentiation assays of hMSCs.  Representative images 
of Alizarin Red, oil-red-o, and alcian blue stained cells demonstrating (B) 
osteogenesis, (D) adipogenesis, and (F) chondrogenesis respectively, after in 
vitro differentiation. A, C and F are stained, undifferentiated control cells of B, D 













Pt. 2 Undiff vs LOG - *** (<0.0001) 
Pt. 3 Undiff vs LOG - ** (0.002) 
LOG Undiff Pt. 2 vs Pt. 3 – ns 
Figure 3.6. Comparison of Patient 2 cells to Patient 3 cells on Graphene for 
Osteogenesis.  Data shows that patient 3 cells perform on graphene films the same 






Figure 3.7. hBMSC on Graphene. Osteogenesis by bone marrow stem cells 






(a)   (b)  
Figure 3.8.   Transduction of Adipose Stem Cells. (a) 24-hour image (b) Day 7 of 








Figure 3.9.  XPS showed an approximate elemental composition of 83.45%C, 
12.48%O, and 4.07%N. Summary of XPS results on rGO sample3 spots were 
investigated and the averages reported for the elements of interest: C, O, and N. 
 spot1 spot2 spot3   
Name  Atomic % Atomic % Atomic % average std dev 
C1s 82.54 83.61 84.2 83.45 0.69 
O1s 13.16 12.48 11.79 12.48 0.56 




Common Acquisition Parameters Table-spot1 
Parameter   
Total acquisition time 11 mins 20.5 secs 
Number of Scans 10 
Source Gun Type Al K Alpha 
Spot Size 400 µm 
Lens Mode Standard 
Analyzer Mode CAE : Pass Energy 200.0 eV 
Energy Step Size 1.000 eV 




Elemental ID and Quantification 
Name  Peak BE FWHM eV Area (P) CPS.eV Atomic % Q  
C1s 285.09 3.05 1712876.45 82.54 1 
O1s 532.36 4.02 660156.20 13.16 1 
N1s 399.92 3.70 138222.48 4.29 1 







Figure 3.11. Raman showed a D-band and G-band situated at approximately 1347cm-1 
and 1588cm-1. When comparing the intensity of these 2 peaks it was determined they 






















Figure 3.12. Representative image of expression of extracellular matrix proteins.  Proteins of Patient 3 adipose stem cells 









Figure 3.13. Representative image of expression of extracellular matrix proteins.  Proteins of Patient 3 adipose stem cells 








Figure 3.14. Representative image of expression of extracellular matrix proteins.  Proteins of Patient 3 adipose stem cells 







Figure 3.15. Representative image of expression of extracellular matrix proteins.  Proteins of Patient 3 adipose stem cells 









Figure 3.16. Representative image of expression of extracellular matrix proteins.  Proteins of bone marrow stem cells 








Figure 3.17. Representative image of expression of extracellular matrix proteins.  Proteins of bone marrow stem cells 








Figure 3.18. Representative image of expression of extracellular matrix proteins.  Proteins of bone marrow stem cells 








Figure 3.19. Representative image of expression of extracellular matrix proteins.  Proteins of bone marrow stem cells 
expressed during cell adhesion at 21 days on reduced Graphene Oxide using immunofluorescence. 
 














Versions of this chapter were originally presented as a Research Day Abstract as 
an oral presentation for the Comparative and Experimental Medicine Department: 
presented in-house only no commercial presentation: 
 










This chapter covers the core, which is Biofabrication. The long-term goal is to 
develop a biocompatible scaffold containing cells and sufficient vascularization using 3D 
bioprinting and bioreactor mechanics to influence the biological processes.  Tissue-
engineering technologies have the potential to provide a more effective approach to 
bone regeneration that will speed healing, improve patients’ chances of recovery from 
debilitating injuries and diseases, and return normal form and function. I hypothesize 
that a new nanoengineered construct composed of graphene-Poly Lactic-co-Glycolic 
Acid (PLGA) will create an environment suitable for mesenchymal stem cell proliferation 
and differentiation for osteogenesis and angiogenesis.  I also hypothesize that in order 
to improve the outcomes in the use of graphene-PLGA materials and mesenchymal 
stem cells, it is important to mimic the signaling pathways that are triggered when cells 
adhere to the construct and also to monitor the changes associated with these 
processes for future scaffold development.  
In this section, we describe the fabrication, physicochemical and biological 
properties of a nanoconstruct generated for musculoskeletal repair.  Scaffolds were 
designed to induce human adipose tissue – derived mesenchymal stem cells 
(hADMSCs) to undergo osteogenesis and angiogenesis. Scaffolds were printed using a 
commercial pneumatic based Aether 1 3D printer. The printer was operated using a 
numerically controlled G-code.  The G-code was designed to obtain a specific hatched 
lattice pattern conducive for bone cell and vascular network formation. The scaffold 
consisted of a blend of two molecular weight forms of PLGAs and a low oxygen 
functionalized derivative of graphene. Human ADMSCs were used to evaluate the 
cytocompatibility and morphology via fluorescent assays of the nanoconstruct. A 
multicomponent nanoengineered graphene-PLGA bone material could form the 
foundation for novel scaffold technology to promote rapid bone regeneration to advance 












Tissue engineering using stem cell regenerative strategies with the aim to 
remodel, replace or regenerate damaged tissues or organs with combining a 
biodegradable scaffold in a three-dimensional matrix to form the ideal bone graft is a 
significant challenge. For generations two-dimensional static cell work has dominated 
the study of cellular response but a shift to a more physiological three-dimensional 
format allowing for the study of biochemical markers and biomechanical stresses (Duval 
et al., 2016).  Biofabrication has been presented as an application of 3D manufacturing 
strategies (Groll,2016). Biofabrication is defined as "the automated production of 
biologically functional products with structural organization from living cells, bioactive 
molecules, extracellular matrix, biomaterials, cell aggregates, through bioprinting or 
bioassembly and successive tissue transformation processes" (Moroni, 2017). In 
general, the biofabricated design provides a provisional 3D device to create a network 
with cells and control their performance in a multiplex process in tissue development 
and regeneration.  No matter the tissue ECM type, a multitude of variables are essential 
when designing the complexity of a scaffold for physiological tissue replacement.  The 
variables of importance in the design layout are architecture, mechanics, 
biocompatibility and the rate of biodegradability having the surface properties for cell 
adhesion, proliferation and differentiation for the biofabricated construct (Figure 4.1).  
Integration of the construct into the body’s ECM allows cells to utilize unique 
mechanosensitive to promote pathological progression for regeneration (Yeung et al., 
2005).  The construct must also be able to stimulate biological pathways with the design 
of pores, topography, growth factors, biochemical ques in vitro and in vivo to intensify 
tissue viability, performance and morphogenesis (Dvir, 2011). 
3D biofabricated constructs consisting of natural and synthetic polymers, with 
adult MSCs presents a novel and biomimetic approach in bone tissue engineering.  
Graphene has been found to be one of the most versatile biocompatible biomaterials 
that can interact with physiological biomolecules for biomedical applications (Shin et al., 
2016). Currently, no studies have reported the osteogenic potential of adult MSCs 





in vivo or in vitro.  Graphene nanomaterials as a scaffold has been shown to increase 
cell proliferation and a positive impact on viability of human adipose-derived stem cells 
(Wang et al., 2016). 3D bioprinting is the arrangement of biological and or synthetic 
materials and living cells in a discrete pattern that is optimal for biomimetic bone tissue 
engineering scaffolds that should be biocompatible, bioresorbable, and have the 
potential to be synthesized in an implantable form. Due to the lack of microvasculature 
the establishment of neovascularization is necessary if tissue engineered devices are to 
be progressive and provide a physical skeleton comparable to the innate extracellular 
matrix to enhance cell adherence, proliferation, and differentiation for bone 
regeneration. 
A nanoconstruct was biofabricated for bone engineering using additive 
manufacturing with a commercial 3D bioprinter, Aether 1 (San Francisco, USA).  A 
consistent and reproducible pattern was biofabricated with the pneumatic based 
bioprinter to print a PLGA-carbon based nanomaterial which consists in the designing of 
PLGA melting protocols to determine extrusion pressures and speed values.  Various 
pressures were chosen based on blending viscosity and printer nozzles 0.2 mm, 0.3 
mm and 0.4 mm diameters for thread runs.  After an extrusion pressure was set, a grid 
platform, one for each speed and nozzle, were printed and evaluated.  Every test was 
conducted multiple times with the results of the analysis suggested the printing 
parameters used to manufacture the 0°/45°/90° deposition pattern with a diameter of 5 
mm.  There were 122 in total, with heights from 0.5mm to 5mm for analysis subject to 
compression test, biological analysis, which consisted in cell seeding of human adipose 
MSCs and viability test, to implants for a rat segmental femur study.  
  
Poly(lactic-co-glycolic) acid (PLGA) and Graphene   
PLGA 
As a linear copolymer PLGA has properties to be used for biofabrication in the 
areas of osteo and angiogenesis. PLGAs utilizations include drug delivery systems, 
biodegradable medical suture and, of course, biofabricated scaffolds for bone and 
vascular tissue regeneration. Due to PLGAs utilizations in having Food and Drug 
Administration (FDA) approval for clinical use, the ability to modify surface chemistry for 





scaffold designs is what makes PLGA the choice for the study. It is highly biodegradable 
in physiological environments which is an imperative property for biomedical device 
applications. PLGA can be processed at diverse ratios within its constituent monomers, 
lactic acid (LA) and glycolic acid (GA) (Figure 4.2).  Different ratios of LA to GA used in 
polymerization can be attained and identify the copolymer by the molar ratio of the 
monomers, 65:35 – 65% LA and 35% GA.   
Dissolving PLGA can be performed by using a number of different solvents, such 
as, chlorinated solvents, chloroform, ethyl acetate, methanol and acetone which allows 
engineering the size, shape and be utilized in biomolecular transport (Makadia, 2011).  
Hydrolysis of the ester linkages is the process for degradation of PLGA.  During the 
degradation process the byproducts lactic acid and glycolic acid are formed, but rates of 
degradation have several variables involved.  First, molecular weight of the polymer 
giving ranges of several weeks to several months for polymer breakdown.  Second, the 
ratio of acids to each other plays a large step in the breakdown with a higher content of 
lactic acid present making the polymer less hydrophilic, thereby absorbing less water 
and consequently degrade at a slower rate.  Higher amounts of glycolic acid drives the 
degradation rate, the ratio 50:50 is an omission to the rule by which this copolymer 
exhibits a faster degradation rate.  The degradation of PLGA has given fabrication and 
biofabrication a great deal of flexibility for many medical device applications.   
 
Graphene 
Graphene is a synthetic material of carbon atoms in a monolayer that is being 
researched in areas from thermodynamics, biosensing and now biomaterials for tissue 
engineering.  Studies have shown that composite materials containing graphene and its 
derivatives can promote adhesion, proliferation, and osteogenic differentiation of MSCs 
in vitro (Caplan, 2005). Graphene is a 2D honeycomb high surface area lattice structure 
that is can be oxidized with or without further functionalization into derivatives for 
nanoengineering. Two- and three-dimensional nanocomposite materials containing 
various forms of graphene, especially oxidized graphene, have been incorporated into 
in vitro cell cultures to study their effect on cell proliferation and differentiation (Caplan, 





and reduced graphene oxide (rGO).  GO is a form of graphene that includes the 
functional oxygen also having functional groups being hydrophilic, such as carboxyl, 
epoxy and hydroxyl, which allows for a higher dispersibility in aqueous solutions and 
better hydrophilicity than pristine graphene (Dikin et al., 2007).  The reduction of 
graphene oxide by chemical treatment yields reduced graphene oxide.  rGO is formed 
and the oxidized functional groups are removed, to obtain a graphene material that 
contains only small amounts of residual oxygen and heteroatoms.   
Adding to polymers, graphene and its descendants have shown to greatly improve 
mechanical properties (Sayyar et al., 2015).  A modification of pristine graphene, which 
result in product similar but distinct from rGO in heteroatom content, was made by the 
University of Arkansas at Little Rock Center for Integrative Nanotechnology Sciences.  
This modification of pristine graphene produced a low oxygen graphene with an oxygen 
ratio of 6% to 10% that will be blended with PLGA and 3D printed for this study (Bourdo 
et al., 2017).    
The combination of the polymer PLGA with a graphene oxide has been explored 
for the utilization of tissue engineering (Shin et al., 2015). Reports from several groups 
including ours have shown that nanocomposites containing graphene and its derivatives 
have varying physical and chemical properties, by virtue of which they can affect cell 
behavior. We and other groups have shown that graphene containing nanocomposites 
can promote adhesion, proliferation, and osteogenic differentiation of MSCs in vitro and 
in vivo (Dubey et al., 2015; Zhang et al.,2011; Elkhenany et al., 2017; Nayak et al., 
2011), making graphene nanoparticles strong candidates for bone tissue engineering. 
Various sources of stem cells, such as ESCs, MSCs, and iPSCs, have been identified 
as potential osteoprogenitors for bone tissue and vascular engineering. Adult MSCs are 
favored because of their multipotency, immuno-modulatory properties, and ability to 
release trophic factors (VEGF). Bone marrow and adipose - derived MSCs have been 
benchmarked as the most applicable cell sources for bone tissue engineering due to 
their well-defined in vitro and in vivo osteogenic differentiation patterns (Al-Nbaheen et 
al., 2013; Barry, 2004; Caplan, 2007; Pittenger, 2008; Storti et al., 2019). Most 
importantly, the use of MSCs alleviates the need to use ES cells which is particularly 





is a need to identify a cell source in the osteoprogenitors i.e., MSCs, which not only 
expresses endothelial cells that produce VEGF, but also demonstrates enhanced 




All biochemicals, cell culture supplements, and disposable tissue culture supplies 
were purchased from Thermo Fisher Scientific unless otherwise stated. In all 
preparation steps, deionized (DI) water from a Millipore system unit with a resistance of 
18M/cm was used. The molecular weights of PLGA were purchased from Sigma-Aldrich 
(St. Louis, MO). The oxidized form of graphene was obtained from our collaborators at 
the University of Arkansas, Little Rock. The reduced graphene oxide form of graphene 
was commercially obtained (Cheap Tubes Inc).  
 
Construct biofabrication 
To fabricate a viable layered orthopedic scaffold to support sufficient osteogenesis and 
vascularization.  Three forms of commercially available PLGA (Sigma Aldrich):  
 1) 50:50 ratio and molecular weights of 30,000-60,000, 
 2) 65:35 ratio and molecular weight of 40,000-75,000 and  
 3) 75:25 ratio and molecular weight of 66,00-107,000 were used. 
 
Functionalized form of graphene, oxidized to give graphene nanoparticles consisting of 
6-10% oxygen was obtained from our collaborators (Dr. Shawn Bourdo’s group) at the 
University of Arkansas at Little Rock, AR. This form of graphene is referred to as low 
oxygen graphene (LOG). The synthesis and physicochemical properties of LOG 
nanoparticles has been described in Chapter 3 and in published papers from our groups 
(Bourdo, 2017; Elkhenany et al., 2017).  1mg powder of LOG was obtained from UALR. 
Another form of functionalized graphene consisting of approximately 12% oxygen 
was obtained from commercial sources from Cheap Tubes Inc (Grafton, VT, USA).  This 
form of graphene is referred to as reduced graphene oxide (rGO). The physicochemical 





specific details of rGO have been described in Chapter 3. 4.0mgs of rGO powder was 
obtained.  
A blend of two molecular weights of PLGA with LOG was used to 3D print the 
construct (Figure 4.4-4.5). The material blend was prepared by mixing 1 gram of each 
form of PLGA with 1 mL DMSO as a solvent in a 2:1 w/v ratio. 1 mg of LOG powder was 
added to the PLGA blend to give a final concentration of 0.05 wt%. The mixture was 
continuously rotated in a rotisserie oven for two hours at 65oC. The mixture was hand 
mixed every 15 minutes to ensure a uniform and complete blending of PLGA and 
graphene. Two iterations with varying molecular weights of PLGA blended with 1.0 mg 
of LOG were generated. On the second day, the mixture was gas sterilized using 
hydrogen peroxide using a 28-minute protocol (Sterilis Solutions, MA).  The blend was 
stored in the pneumatic syringe at -20oC until use. Two iterations of the nanoconstructs 
consisting of 50:65 and 50:75 molecular weights of PLGA blended with LOG were finally 
fabricated. 
The polymer/graphene blends were removed from the freezer and brought to 
room temperature before loading the syringe onto the printer. The scaffolds were 
printed on tissue culture polystyrene dish with the platform temperature maintained at 
15 to 30 °C.  The temperature required for extrusion depends strongly on the molecular 
weights and inner diameter of the nozzle. The extrusion was conducted with 4-6 bars 
pressure with an average of 0.5-1.0mm/s using a 0.2mm to 0.3mm inner diameter 
nozzle. The choice of the inner diameter of the printer nozzle provides a great balance 
between speed and precision. The printed scaffolds were kept at -20oC to preserve the 
design. The printed scaffolds were removed from the freezer and used either in vitro or 
in vivo.   
 Each scaffold was subjectively evaluated while printing and at completion. If visual 
inspection found it unsatisfactory, the polymer blend was reheated and reprinted. 
 
3D Bioprinter Setup 
The PLGA/graphene nanoconstructs were printed using the 3D printer called 
Aether 1, made by a small start-up company, Aether in San Francisco, CA.  It is in the 





College of Veterinary Medicine (Figure 4.6).  Pneumatic extrusion-based printing was 
used.  Unlike in FDM, where extrusion is a gear driven system, bioprinting nozzle in 
Aether 1 is pressurized, therefore pressure dictates extrusion flow.  Aether is an 8 
pneumatic syringe extruder with a vertical retraction system with one anodized 
aluminum heated syringe mount, double head FFF hot end filament extruder and 
solenoid microvalve droplet jetting extruders which all move along the x-y axes, while 
the anodized aluminum heated stage moves along the z axis.  Printer chamber has UV 
blacklight LED lighting system, automatic syringe tip cleaning areas, and center 
attached camera.  The printer comes with an external air compressor, which provides 
air flow on a range of 2 to 100psi.  The syringe units allow for nozzles of different 
gauges for material selections.  Heated syringe allows to print high heat polymers and 
the microvalve droplet jetting allows printing of different kinds of cells in single or double 
syringe loads.  
The main features of Aether 1 are as follows: Extrusion System – Pneumatic 
based, Print Heads – 1 Heated 30cc Pneumatic Print Head as well as 7 Pneumatic 
Syringe Heads and 2 FFF Hot End Filament Extruders, Air Supply – External 
Compressor, UV Crosslinking Wave Lengths - 365 nm & 405 nm, X / Y Axis - 1.055 
micron [0.001055mm], Z Axis - 0.43 nanometers [0.00000043mm], Operating Pressure- 
13.78kPa (0.13 Bars) - 689.47 kPa (6.89 Bars), Layer Resolution - 100 μm. 
 
Biofabrication Design Parameters 
 
CAD Software: The scaffold for biofabrication was designed using a CAD software, 
Autodesk Fusion 360. The goal was to fabricate a scaffold with a pattern consisting of 
alternating angles of 45o and 90o. 
 First, a 2D design was laid out to specify the contact angle of the scaffold.  The 
aim was to replicate the nozzle path on the stage.  A 5mm diameter circle was formed, 
and a layer-by-layer build was made to match the rat femur design.  Vertical lines for 
each guideline were laid out in lengths from left to right format with 0.30mm apart 
making the first single scaffold layer.  Once the single layer is completed, the two 
construct prototypes could be made as an assembly of the design. The first layer was 





z-axis and rotated 45°. This operation was repeated until the desired geometries were 
achieved. The final pattern consisted of 15 layers for the 5mm high (Figure 4.6). 
 A critical point is to maintain construct porosity within the layers. The filament gap 
and layer orientation of 0°/90°, 0°/45°/90° must be considered when seeding sells for 
differentiation.  Once the porosity values are set the strand diameter must be chosen 
which is evaluated by the combination of the bars of pressure and speed, along with 
your strand distance which may change as well, since its value includes the porosity 
gap value for the adjustments of the strain diameter 
 
Slicer: Once the CAD which is represented as .stl file is complete, it is then loaded in 
the slicing software, Element. The scaffold design from the CAD is a series of 
bidirectional cross sections, which is then processed by the slicer software, creating a 
mathematical interpretation of the design. Element software provided with Aether1 
bioprinter sets the slicing parameters, print dimensions, as well as the post processing 
script. The slicing software effectively translates the 3D scaffold into a control language 
known as a G-code file (Figure 4.7 - 4.10).   Programming parameters such as print 
bed temperature, stand thickness, extruder temperature, flow rate speed and pneumatic 
pressure are the main parameters set manually for the bioprinting process.   
 
Layer height design: Layer height thickness is a measure of the layer height of each 
consecutive addition in the process.  The layer height is crucial to the design of the 
vertical resolution of the z-axis.  A layer height was reviewed in two methods, 2.5mm or 
a full 5mm height, one for the plain PLGA double molar ratio iteration and one for the 
PLGA double molar ratio/LOG iteration based on the femur model.  This is an important 
consideration in the design of the constructs because we intend to use it in a weight – 
bearing rat femoral defect model. Some stability issues could arise, if the strand 
diameter is thin (0.2mm) and the layer height is low. It could cause the structure to 








Physicochemical and biological testing 
Instron Compression Test 
After multiple prints of each iteration, analyses were conducted.  Mechanical 
analysis consisted in compression on 3D PLGA 50:50+65:35+LOG and PLGA 
50:50+75:25+LOG with a 5 mm diameter, 5mm height and 0°/45°/90° deposition pattern, 
so to evaluate scaffolds mechanical properties. The test was conducted using an 
INSTRON 5965 (Illinois Tool Works Inc, Norwood, MA), compressed until 2.5mm/min 
deformation was reached (Figure 4.11).   
 
Scanning Electron Microscopy (SEM)  
SEM allows for imaging the morphology of the biofabricated construct so as to 
gather data on the physical characteristics of topography, spatial distribution of the 
thread spacing and porosity and analyze the variability in the materials composition.  All 
of these factors are fundamental to evaluate the functional biocompatibility of a 
biomaterial.  The constructs were prep in the lab using a SEM protocol.  Samples were 
place in vials.  Next, a fixative solution of glutaraldehyde was poured to cover samples 
at room temperature 2 hours.  Samples were then washed 3 times with 0.1M of 
phosphate buffer for 10 minutes each.  Osmium solution prepped at 2% was then 
poured over the samples for 2 hours at room temperature and kept in a dark location.  
Samples were then washed 3 times with 0.1M of phosphate buffer for 10 minutes each.  
Dehydration sequence was then performed by taking EtOH in increasing order of 
30%/50%/70%/80%/90%/96%/100% - each percentage was for 15 minutes.  Samples 
were then placed in desiccator overnight then take to the scope for imaging.  
 
Calcein Assay 
 Calcein-am staining was used to appraise viability cell and proliferation on the 
PLGA-graphene construct.  Calcein-am is a non-fluorescent compound that permeates 
the cellular membrane of living cells, where intracellular esterase is immediately 
hydrolyzed, a process that transforms the calcein-am to calcein identifying cell viability 
on the material.  50,000 cells were seeded per sample of PLGA+graphene for 48 hours.  





μg/ml calcein-am reconstituted with dimethyl sulfoxide, for 5 minutes at 37°C, and the 
fluorescence was viewed on Lecia fluorescent microscope. 
 
Biodegradation Assessment Study 
Biodegradable polymers such as PLGA in a physiological environment can 
degrade gradually and then dissipate following implantation. This degradation is critical 
for tissue-engineering operations, on account of the polymer dissipating as functional 
tissue regenerates. Interactions of cell-matrix interactions with an assortment of 
biodegradable polymers have been studied (Gentile, 2014). The hydrolytic 
biodegradation of PLGA may contribute an additional level of regulation over cellular 
interactions: during degradation progress, the surface of the PLGA is constantly 
renewed by physiological enzymatic reactions, providing a dynamic substrate for cell 
attachment and growth. This focused on the degradation properties of the mixed molar 
iterations of the PLGA and carbon-based nanomaterial. The iterations will be compared 
in the effects of the ionic content of phosphate buffered saline (PBS) on the 3D printed 
degradation properties.  Therefore, in this study the direct in vitro degradation of PBS 
solution with a designed continuous flow-spinner bioreactor, that can flow fluids through 
the porous scaffolds in a controlled environment.  The construct was systematically 
inspected to reveal the variations in morphological changes and in terms of degradation 
rate analyzed weight loss of the 3D printed PLGA composite construct. Then, the 
different reactions can be compared to fully understand the reactions in vivo which may 
be closely resembled by the degradation in in vivo. Each scaffolds iteration will be 
placed into the continuous flow-spinner flask bioreactor at 37°C with 5% CO2 and 
spinner at 65rpm and peristaltic pump at 55mLs per min. Initial dry weight was taken 
and initial wet was taken at 48 hours in each solution.  Samples weights will be 
collected each week for 8 weeks for analyses and the PBS solution will be replaced 
weekly.  At predetermined time points, the construct pieces were removed from the PBS 
solution and quickly washed with DDI water to remove excess salts or solution 
accumulation on the surface. The scaffolds are air dried for one hour then weights were 








In this study we chose a novel blend of two different molecular weights of PLGA 
each with two different iterations of carbon – based nanoparticles to form a 
nanoconstruct conducive for osteogenesis and angiogenesis of mesenchymal stem 
cells. PLGA is an FDA – approved, biodegradable polymer commonly used in 
biomedical research and 3D printing. The two molecular weights of PLGA were chosen 
because of their distinct degradation properties (Gentile, 2014), with a long - term goal 
of providing a structure to support new and damaged bone and vasculature. 
The pattern design and topography of the biofabricated scaffolds has to meet the 
native tissue architecture to have a strong development and achievement for a positive 
cell behavior.   The basement membrane of the ECM forms a multi complex mesh of 
pores, fibers, ridges and contact angles (Yang, 2011).  Contact guidance of cells guided 
by topographical cues mimicking the ECM independent of biochemistry is the reasoning 
of using PLGA and carbon-based nanomaterials for the advancement of adhesion, 
migration and differentiation to promote changes in cytoskeletal organization and gene 
expression.  The pattern designs were fabricated to attain 75-80% porosity, between 
100 and 300 µm interconnectivity, with contact angles at 45 and 90° to support the 
osteogenic and angiogenic potential of mesenchymal stem cells. 
The biofabricated blend and CAD design were chosen corresponding to support 
the bone’s ECM architecture, which shows a polymer that is bioactive, biocompatible 
and controllable biodegradability, so to support bone behavior for all the regeneration 
development. 
 
Identification of solvents on PLGA for Fabrication 
There are reports to show various different solvents for PLGA polymers (Guo et 
al., 2017).  We first started out using an emulsion based solvent combination. The 
organic solvent chloroform was used to dissolve the two molar ratios of PLGA with the 
blending of the carbon-based nanomaterial.  Methanol was then added to the mix to 
induce a PLGA+nanomaterial precipitate.  This mixture worked will but the needed 





Printing with 0.2mm and 0.3 mm nozzles did produce a thread. The mixing of double 
molar ratios caused viscosity that was challenging to work with.  The target thread size 
was 200 m to 300 m diameter, for which a full height of 5 mm.   
We then moved to the study using DMSO.  DMSO is a polar, aprotic solvent that 
is frequently utilized in biomedicine and cell culture research.  This solvent can 
breakdown polar and nonpolar compounds, including all molar ratios of PLGA.  DMSO 
plays a dual role allowing increased mobility at lower temperatures and as a polar 
aprotic solvent shield’s ester bonds allowing for minimal degradation from hydrolysis 
reducing biodegradation while in vitro and in vivo (Dong, et al., 2006).  
We were able to accomplish a visually homogenous mixture of the two scaffolds 
each with different molar ratios of PLGA with carbon-based nanomaterial and DMSO.  
In our hands, DMSO was found to be suitable and hence, was used as the solvent for 
the blending process.  When constructs were placed in -20oC the DMSO would also be 
used as a cryoprotectant.  
 
Identification of Fabrication and Printing Conditions 
 General characterization consisted of the extrusion of material design with 
changes in CAD or written in the G-code to evaluate material threading diameter using 
different nozzle sizes, pneumatic pressure and extrusion speed values. Results from 
multiple test prints using 0.2 mm and 0.3 mm nozzles at PSI test ranging from 65 to 95, 
temperature ranges 45oC to 90oC and speeds 0.2 mm/s to 1.0 mm/s with heights of 1-
5mm’s.  The addition of the carbon-based nanoparticles did not alter the viscosity or 
presented any print pattern issues.   
 The evaluation of the bioprinter’s behavior when it came to changes in 
temperature variations and pneumatic pressures were applied to find the best 
pressure/speed combination that will provide a diameter thread for detailed design and 
porosity of the construct.  After comparison of data between 0.2 mm and 0.3 mm 
nozzles for thread diameter to build the construct were compared and the 0.2 mm 
nozzle showed smooth clean threads with a consistent thickness. Extrusion speed of 
0.6 mm/s was chosen for both material blends while the pneumatic pressure was set at 





1 was obtained at the settings listed - Pressure 5-6 bar, Temperature 65oC, Extrusion 
speed 0.6 mm/s and Nozzle 0.2mm. 
Each construct print time was 2 hours and 14 minutes. 88 iterations of each 
molar ratio were made at 0.5 mm high, and 36 iterations of each molar ratio were made 
at 5 mm high dimensions.  These contracts were printed to be tested in multitude of 
levels from cellular culture studies, mechanical and degradation stress and in vivo study 
to follow.   
 
Compression Test 
Mechanical characterization consisted of a compression test done on the Instron 
unit. This test was carried out using an animator, until 50% deformation level was 
reached being 2.5 mm tall. Compression test showed that the Young’s modulus of the 
PLGA/carbon-based nanoparticles/DMSO scaffolds for 50:50-65:35 was 224.657 MPa 
while that of 50:50-75:25 was 268.104 MPa.  These values were similar for the 
nanoconstructs containing LOG and rGO (Figure 4.12 – 4.13). Results showed a 
PLGA/ DMSO with carbon-based nanomaterials can handle compression needed for 
bone tissue engineering.   
 
Sterilization   
All iterations of PLGA and graphene mixtures were sterilized using multiple methods.  
1. Steam using a 30 min cycle. 
2. Gas - hydrogen peroxide gas using a 28 min cycle,  
3. -20 to -80 freezer for 4h hours 
4. Ultraviolet light - 2-4 hours of exposure.  
Visual evaluation was first performed for each method.  Subsequently, each scaffold 
was tested for cytotoxicity using human mesenchymal stem cells for a seven-day 
period. All samples tested with calcein AM cell viability assay.  Each method of 
sterilization showed they could support cell life on the material as well as proliferation. 
None of the samples showed any bacterial or fungal contamination.  Freezer method 
was chosen for future storge and preparations of the blend.  The blend was also stored 





constructs printed at 0.5 mm high were sterilized in -20oC freezer for several day and 
then one hour of UV radiation before seeding with adult human adipose mesenchymal 
stem cells.  Viability of cells measured a calcein assay showing sales biocompatibility 
with the construct design. To further show biocompatibility cells were seated and track 
starting at 24 hours going to 21 days by images for proliferation.   
 
In vitro Biodegradation  
 PLGA+graphene at 50:65 and 50:75 blend was maintained for 8 weeks in order 
to determine the degradation rate on the membrane. The samples were kept at 36.8oC 
to 37.2oC with a magnetic stir bar set at 65 rpm and a peristaltic pump set at 50mL/min.  
This unit ran 24 hours a day with material checks one time a week per protocol.  Each 
week material fatigue could be seen by eye and a weight chart was kept.  Week 7 each 
blend constructs microporous matrix began to show cracks that could been seen 
without magnification.  Crystals were found scattered on the surface of the construct 
membrane.  Weight loss are numbers used for the degradation index. Both constructs 
showed limited weight loss that could be explained by the residual DMSO which has 
been shown to reduce the degradation of PLGA by buffering of the ester bonds (Guo, 
et. al., 2018) (Figure 4.14). Furthermore, it is thought that crystal formation on the PBS 
may also play a role in the measurements which could skew the actual mass 
degradation. Future studies using simulated body fluids will need to be performed to 
have a stronger understand of PLGA biodegradation.  
 
Scanning Electron Microscopy 
The topography of the 3D biofabricated construct was assessed using SEM.  As 
shown in figure 4.14 (Figure 4.15 a-e), the presence of thread structure, valleys, 
roughness and porosity are visible and replicated on the constructs.  Figure 4 (f) was 
imaged to show cell attachment on surface with extensive filopodia on the construct.  








Cell Proliferation and Viability 
The calcein Live/Dead fluorescent analysis was conducted to evaluate 
cytocompatibility and proliferation on the PLGA+LOG construct post 48-hour seeding.  
Seeding was completed throughout the construct.  The evaluation and imaging of 
calcein-am on the PLGA+LOG construct was present confirming proliferation and 
cytocompatible on the construct, but fluorescence was weak (Figure 4.16).  Leading to 
the next study of seeding the constructs with transduced MSCs.   
 
Cell Proliferation and Attachment 
At multiple time points the during the culture period, the distribution of the GFP 
and RFP transduced adipose MSCs were investigated on PLGA+LOG and PLGA +rGO 
contracts. The visualization of the cells was imaged using a fluorescence microscope 
showing PLGA+LOG using RFP cells and PLGA+rGO using GFP cells (Figure 4.17 -
4.20).  The images show live cells on the construct at 24 hours and 7, 14, and 21 days 
of the culture.  Close to 100% cell viability with cells present throughout the construct 
with no problems in proliferation morphology and reduction in color.  This methodology 
is repeatable for cells and can definitely be utilized in future studies for tracking 





The advancement of additive manufacturing techniques, such as 3D 
Biofabrication / Bioprinting, helps in creating 3D biocompatible implants on which 
multiple cell types can be seeded.  This progress in technology gives an encouraging 
substitute to autogenous bone grafting and growth in material science development.  
In this chapter, the architecture of a micro and nano cylindrical 0°/45°/90° 
construct was biofabricated, via additive manufacturing technique, in precise 3D 
bioprinting, and in conclusion analyzed.  Those 3D constructs were designed of 
compounded material, of 2 different molar ratios of PLGA matrix to mimic the ECM and 
reinforced a carbon-based nanoparticle, which to support differentiation of cells for 





 This study provided data to show that we were able to successfully fabricate 
PLGA/carbon nanoparticle nanoscaffolds, which exhibited adequate mechanical 
strength, biodegradation, and in vitro biocompatibility. These results warrant in vivo 
application in a long bone defect model to fully understand and evaluate the 
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Figure 4.1. Design layout should provide a three-dimensional space and meet as many 











P2191-5G 50:50 Mol wt. 30,000 – 60,000 
P2066-5G 65:35 Mol wt. 40,000 – 75,000 
P1941-5G 75:25 Mol wt. 56,000 – 107,000 
  
     (b.)  
Figure 4.2 (a). Sigma-Aldrich codes and PLGA ratios used. (b) Chemical structure of 














   
Figure 4.5. Layout of prints from blend mix of two molar ratios of PLGA+LOG showing a 







Figure 4.6. Aether 1 Bioprinter at the College of Veterinary Medicine, Large Animal 














Figure 4.7. Biofabrication design – Autodesk 360 software views, (a) Front view, (b) 






Figure 4.8. G-code that repeats for each layer. Above is 1layer of code.  
G CODE  
; Generated with MatterSlice 1.0 
; filamentDiameter = 1.75 
; extrusionWidth = 0.2 
; firstLayerExtrusionWidth = 0.2 
; layerThickness = 0.1 
; firstLayerThickness = 0.1 
; automatic settings before 
start_gcode 
G21 ; set units to millimeters 
M107 ; fan off 
; settings from start_gcode 





; automatic settings after start_gcode 
G90 ; use absolute coordinates 
G92 E0 ; reset the expected extruder 
position 
M82 ; use absolute distance for 
extrusion 
M78 B1 P99 D0 
M109 T2 S60 
T0 B1 
M205 X10 
; Layer count: 50 
; Layer Change GCode 
; LAYER:0 
M205 X5 








M87 B1 D0 
M78 B1 D1 
M86 B1 D1 
G1 F16.5 X147.719 Y88.236 
G1 X147.719 Y91.763 
G1 X147.739 Y91.81 
M400 
M86 B1 D0 
G0 Z1.3 
G0 F4800 X147.139 Y90.453 
G0 Z0.05 
M400 
M86 B1 D1 
G1 F16.5 X147.12 Y90.109 
G1 X147.128 Y89.679 
G1 X147.139 Y89.559 
M400 
M86 B1 D0 
G0 F4800 X147.144 Y90.546 
; TYPE:FILL 
M400 
M86 B1 D1 
G1 F16.5 X147.12 Y90.109 
G1 X147.128 Y89.679 
G1 X147.139 Y89.559 
M400 
M86 B1 D0 
G0 F4800 X147.144 Y90.546 
; TYPE:FILL 
M400 
M86 B1 D1 
G1 F16.5 X147.199 Y90.97 
M400 
M86 B1 D0 
G0 Z1.3 




M86 B1 D1 
G1 F16.5 X148.319 Y92.347 
G1 X148.319 Y87.652 
G1 X148.339 Y87.625 
M400 
M86 B1 D0 
G0 Z1.3 
G0 F4800 X148.939 Y87.303 
G0 Z0.05 
M400 
M86 B1 D1 
G1 F16.5 X148.919 Y87.318 
G1 X148.919 Y92.681 
G1 X148.939 Y92.696 
M400 
M86 B1 D0 
G0 Z1.3 
G0 F4800 X149.499 Y89.137 
G0 Z0.05 
M400 
M86 B1 D1 
G1 F16.5 X149.519 Y89.113 
G1 X149.519 Y87.145 
G1 X149.539 Y87.139 
M400 
M86 B1 D0 
G0 Z1.3 
G0 F4800 X150.099 Y87.104 
G0 Z0.05 
M400 
M86 B1 D1 
G1 F16.5 X150.119 Y87.105 
G1 X150.119 Y89.009 
G1 X150.139 Y89.013 
M400 
M86 B1 D0 
G0 Z1.3 
G0 F4800 X150.739 Y89.339 
G0 Z0.05 
M400 
M86 B1 D1 
G1 F16.5 X150.719 Y89.292 
G1 X150.719 Y87.197 
G1 X150.699 Y87.187 
M400 
M86 B1 D0 
G0 Z1.3 
G0 F4800 X152.499 Y88.541 
G0 Z0.05 
M400 
M86 B1 D1 
G1 F16.5 X152.519 Y88.604 
G1 X152.519 Y91.395 
G1 X152.499 Y91.458 
M400 
M86 B1 D0 
G0 Z1.3 
G0 F4800 X150.731 Y90.68 
G0 Z0.05 
M400 
M86 B1 D1 
G1 F16.5 X150.715 Y90.711 
G1 X150.719 Y92.802 
G1 X150.699 Y92.812 
M400 
M86 B1 D0 
G0 Z1.3 




M86 B1 D1 
G1 F16.5 X150.778 Y90.544 
G1 X150.83 Y90.436 
M400 
M86 B1 D0 
G0 Z1.3 




M86 B1 D1 
G1 F16.5 X150.119 Y90.995 
G1 X150.119 Y92.894 
G1 X150.099 Y92.896 
M400 
M86 B1 D0 
G0 Z1.3 
G0 F4800 X149.539 Y92.86 
G0 Z0.05 
M400 
M86 B1 D1 
G1 F16.5 X149.519 Y92.854 
G1 X149.519 Y90.882 
G1 X149.499 Y90.859 

















Figure 4.10. Display of Element model view showing Layer-Layer move of Nozzle while 






           






Figure 4.12. Young’s modulus of the PLGA/carbon-based nanomaterial/DMSO 


























1 5965B13341 2.50026 188.19717 224.65766
Maximum 2.50026 188.19717 224.65766
Mean 2.50026 188.19717 224.65766
Minimum 2.50026 188.19717 224.65766
Load at Yield (Zero slope)
[N]
Extension at Yield (Zero
slope)
[mm]
Load at Total creep
[N]
Extension at Total creep
[mm]
1 ----- ----- 188.20639 2.50026
Maximum ----- ----- 188.20639 2.50026
Mean ----- ----- 188.20639 2.50026
Minimum ----- ----- 188.20639 2.50026



































1 5965B13341 2.50087 210.64801 268.10427
Maximum 2.50087 210.64801 268.10427
Mean 2.50087 210.64801 268.10427
Minimum 2.50087 210.64801 268.10427
Load at Yield (Zero slope)
[N]
Extension at Yield (Zero
slope)
[mm]
Load at Total creep
[N]
Extension at Total creep
[mm]
1 ----- ----- 210.70533 2.50087
Maximum ----- ----- 210.70533 2.50087
Mean ----- ----- 210.70533 2.50087
Minimum ----- ----- 210.70533 2.50087















   
Figure 4.13. Young’s modulus of the PLGA/carbon-based nanomaterial/DMSO 



























1 5965B13341 2.50026 188.19717 224.65766
Maximum 2.50026 188.19717 224.65766
Mean 2.50026 188.19717 224.65766
Minimum 2.50026 188.19717 224.65766
Load at Yield (Zero slope)
[N]
Extension at Yield (Zero
slope)
[mm]
Load at Total creep
[N]
Extension at Total creep
[mm]
1 ----- ----- 188.20639 2.50026
Maximum ----- ----- 188.20639 2.50026
Mean ----- ----- 188.20639 2.50026
Minimum ----- ----- 188.20639 2.50026



































1 5965B13341 2.50087 210.64801 268.10427
Maximum 2.50087 210.64801 268.10427
Mean 2.50087 210.64801 268.10427
Minimum 2.50087 210.64801 268.10427
Load at Yield (Zero slope)
[N]
Extension at Yield (Zero
slope)
[mm]
Load at Total creep
[N]
Extension at Total creep
[mm]
1 ----- ----- 210.70533 2.50087
Maximum ----- ----- 210.70533 2.50087
Mean ----- ----- 210.70533 2.50087
Minimum ----- ----- 210.70533 2.50087















                                            
(a)
 
(b)     (c)  
Figure 4.14 (a)Both constructs showed limited weight loss that could be explained by 
the crystal formation on the PLGA by the PBS. (b)PLGA+LOG at start. (c)at 8-week time 
point of degradation in dynamic bioreactor. 
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Figure 4.15. SEM images of microarchitecture of blended PLGA with LOG. (a - c) 
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 (a)      (b)  
 Figure 4.16. Cell viability and adhesion on PLGA+LOG construct using calcein-am   


















Figure 4.17. PLGA+LOG utilizing RFP cells to track proliferation at (a) 50:50/65:35 at 


















Figure 4.18. PLGA+LOG utilizing RFP cells to track proliferation at (a) 50:50/75:25 at 















Figure 4.19.  PLGA+rGO utilizing GFP cells to track proliferation at (a) 50:50/65:35 at 















Figure 4.20. PLGA+rGO utilizing GFP cells to track proliferation at (a) 50:50/75:25 at 24 









IN VIVO MODEL TO EVALUATE OSTEOINDUCTION, 











Surgeon’s face some of the most challenging bone deficiencies. Reconstruction 
is limited to patient autografts or some biomedical device implant to facilitate bone 
regeneration.  Bone tissue engineering focuses on therapeutic concepts to by using the 
applications of cellular biology, chemistry of material science and biomedical 
engineering by utilizing small animal model for translation.  Therefore, this section of the 
study is to investigate multiple rat models using a novel 3D biofabricated PLGA and 
carbon-based nanoparticle construct in an intramuscular implant model and a 
reproducible 5mm critically sized mechanical load bearing segmental femur defect 
model.  An analysis of the results including radiological, immunohistochemical staining 










The examination of the biological mechanism was described in 1959 with 
experiments in spinal fusion treatment by Hurley et al called the “Guided Bone 
Regeneration” (GBR) (Hurley et al., 1959).  The understanding of GBR is the 
development of a mechanical barrier that is transplanted to the site to prolong cells 
migrating to the site such as fibroblast from surrounding tissue that will impede bone 
development.  In hopes that favored cells such as osteogenic and pluripotent cells from 
the bony tissue or periosteum promote growth in the defect (Liu, 2014). 
 The regenerative process in the body for bone tissues experiences the same 
healing demeanor as other tissue wounds.  First step following the initial damage to the 
tissue is hemostasis.  Platelet activation along with vascular eruption are seen at the 
site.  Immediately growth and clotting factors are supporting the coagulation cascade as 
the platelets pack the vasculature to form a stable clot of fibrin (Thiruvoth, 2015).  The 
recruitment of cells stimulating multiple signaling cascades in response to the 
inflammation process such as polymorphonuclear (PMN) cells and later macrophages 
are import to debris removal (Wang, 2006).  The continued stimulation of a great many 
factors in the immune process continues as the end result is proliferation of new 
supported tissue.  The process of healing the bone matrix is complex hoping the end 
result of the biofabricated construct stimulates recruitment and differentiation of MSCs 
to the osteoblast lineage and the local osteoblast further stimulates the extracellular 
matrix for new bone formation.  The 3D biofabricated nanoconstruct must try to meet 
the grafting gold standard for bone healing and repair.  Will the construct stimulate 
differentiation of endogenous or transplanted cell lines to formation being 
osteoinductive? Is the construct osteoconductive by providing a 3D frame for uniformity 
and growth on the surface.  Osseointegration is the balanced anchorage of a construct 
accomplished by direct bone-to-construct contact.  The model of a critical sized 
segmental defect is the most important approach of taking a biocompatible biofabricated 






Bone: Complex Structure 
Highly dynamic, complex nanocomposite architecture and intricate cellular 
composition is the makeup of the structure bone.  Bone physiology is an understanding 
that is crucial for tissue engineers to take a biofabricated construct from bench to 
surgical setting.  The composition of this organ has components that are organic and 
inorganic leading to its complexity.  Type I Collagen and water is the organic phase 
allowing viscoelasticity and rigidity, while hydroxyapatite matrix makes up the complex 
stiffness and structural reinforcement composing the inorganic component and non-
collagenous proteins responding from cellular behavior forming a microenvironment 
(Webster, 2007).  This complexity is based on a system structural architecture forming 
at diverse levels including cortical and cancellous bone at the macroarchitecture, 
osteons and Harversian system at micro, lamellae at sub-micro, minerals and fibrillar 
collagen at the nanoarchitecture and finishing at the sub-nano with collagen, minerals 
and non-collagenous proteins (McAllister, 2007).  Trabecular bone containing increased 
porosity is at the distal and proximal ends surrounded by a layer of cortical bone to 
progress the transfer of the articular load (Webster, 2007).  This transfer in the load 
stimulus in a healthy bone has been described in many studies using Wolff’s law (Frost, 
1994).  Biofabrication must also understand the complex porosity within the bone 
structure.  With a porosity range of 50-90% of its average 1mm spacing for trabecular 
bone and 3-12% for cortical bone makes a complex geometrical structure remodeling 
challenging (Barrère et al. 2008).  
 The structure further broken-down into layers at a microscopic range 
shows that mineralized collagen fibers stacked in layers in a parallel form called lamella 
are approximately 3-7 micrometers and staked in a +/- 45o forming the trabecular struts.  
Replicating the lamella in bone engineering is very important as their formation contains 
the Haversian canal which contains the blood vessels and nerve for bone support and 
nutrition (Rho, 1998).  The dynamic properties of bone are controlled by a very 
intertwined activity of cells: osteoblast – bone forming, osteoclast – bone consumer and 
osteocytes- bone remodeling mechanosensors, that reside in the intramedullary canal 
within the bone marrow (Marks, 2002). Bone is continuously remodeling tissue based 





and mineralization make up the composition and the cortical and trabecular orientations 
and architecture describes the mechanical properties.  From a biofabrication 
geometrical analysis of the bone matrix a material design needs to be a composite 
material that supports the lamellar matrix design, influences cell behavior, biodegrades 
the same as the remodeling activity and further stimulates the mechanical properties of 
bone. 
 
Experimental model – Critical size defect 
With the advances in biofabrication focusing on multiple forms of engineering to 
optimize organ growth two important needs that must be maintained and considered, 
first the biocompatible biomaterial and second the animal defect model, to calculate 
outcomes and effectiveness of the construct.  When establishing model design, you 
must develop a standardized process in evaluating the needed tissue growth of study, 
which is osteogenesis for our team.   The model must have a “critical size defect” (CSD) 
which was defined by JP Schmitz stating that the animal of the study must have the 
smallest diameter intraosseous damage in the appropriate bone that will not regenerate 
spontaneously during the lifetime of the model (Schmitz, 1986).   
 
Femur segmental defect  
To determine if the biofabricated construct complies with the qualifications of 
biocompatibility and mechanical strength, the construct must be accountable to testing 
in vitro and in vivo. A segmental long bone defect in order to be a critical size is 
configured by multiplying 2.0-2.5 by the diaphyseal diameter (Garcia-Gareta, 2015). 
From a researcher’s perspective and communication with both human and animal 
orthopedic surgeons that long bone segmental trauma are the most demanding graft 
sites to repair to support load bearing issues.  The implant to the graft site being natural 
or synthetic most undergo physiological stress soon after implant, in defiance of the 
surgeon’s approach in which internal fixation support, but also experiences lack of 
vascular coverage to support bone regeneration and tissue repair.  The content and 
structural design must intel mechanical properties to take load bearing stress as well as 





The mechanical characteristics of the biofabricated construct must complement the 
bone graft surroundings not allowing for structural failure which is imperative to allow 
advancement of tissue repair.  The engineered external construct must support sensory 
transduction to support mechanical signals to stimulate surrounding progenitor cells into 
differentiation of the desired new tissue (Tzioupis, 2007).  With the 5mm critical size 
defect being reproduced successfully and by implanting our PLGA-LOG construct we 
are now investigating the potential for osteogenesis.   
 
Osteoinductive Study of PLGA+LOG Biofabricated Construct 
An osteoinduction study is an important process in the biofabrication of a 
possible bone construct.  This process is defined in which osteogenesis occurs by the 
implantation of a biomaterial in the pocket of connective tissue with the result of new 
bone formation.  Chai et al. 2012 states that osteoinduction has many factors that must 
be met by the biomaterial (Chai et al 2012).  Properties should include surface 
topography including all levels architectural geometry, composition solubility effect of 
the biomaterial, inflammatory response that stimulates chemotaxis of osteoclast to the 
biomaterial, and the implantation site and healing time of the animal model (Li et al., 
2011, Chai et al., 2012).  The biofabricated biomaterial should activate bone formation 
heterotopically, implying the enlistment of immature cells and the stimulation of these 
cells to expand into precursors of mature bone cells to support the impute of the 
biomaterial’s properties are osteoinductive and not stimulated by osteoconductive 
formation by the implantation (Davies, 2000).   Analyses of osteoinduction helps to 
understand the mechanism of bone healing in the presence of the construct when used 







Construct Biofabrication – For Intramuscular and Femur Study 
Intramuscular and femur constructs were biofabricated from double molar ratio 
PLGA+LOG using additive manufacturing with the Aether 1 bioprinter as previously 
described in chapter 4.  Construct outer and height dimensions remained.   On day of 
surgery acellular constructs were removed from -20oC freezer and placed under UV 
irradiation for 1 hour before implant.  Cellular constructs were removed from -20oC 
freezer and placed under UV irradiation for 1 hour then seeded with 1x106 hADMSCs 
and incubated overnight.  Constructs were brought to operating room one at a time as 
needed for implant.  
 
In-vivo Intramuscular Study 
Surgical Procedure 
All animal handling and surgical procedures were strictly conducted under the University 
of Tennessee Institutional Animal Care and Use Committee (IACUC). 
 
Each group consisted of 6 Sprague-Dawley rats 8-12 weeks old and weighing 
between 225 and 240g a muscle implantation of a biofabricated construct to evaluate 
the osteoinductive capacity of a construct in bone healing.  Evaluation of osteoinductive 
potential of a novel construct will provide valuable information on the mechanism by 
which the progenitor cells undergo differentiation.  Each patient will be anesthetized with 
isoflurane at 1.5 to 2% with 2 L/min Oxygen by induction tank then placed on mask 
support for remaining time in the operating room.  Before surgery, each rat will be given 
the analgesic buprenorphine (0.05 mg/kg) based on IACUC protocol. Next, removal of 
hair from the hindquarter, using small clippers.  The skin area was then prepped for 
sterility with chlorhexidine and alcohol.  While holding the skin taught, using a sterile 
blade, make a longitudinal incision of about 10-12 mm, and the entire femoral shaft will 
be exposed using blunt dissection.  Using thumb forceps to hold the edge of the skin 
and slowly separating the skin from the muscle using Metzenbaum scissors.  Using the 





or cellular construct was carefully inserted into the muscle pocket.  Suturing the fascia 
overlying the muscle was done using 4-0 PDS resorbable suture.  Closure of skin 
incision was completed with 4-0 suture.  For the 3 days postoperative, the rats will be 
given buprenorphine injection every eight to twelve hours for pain management and 
antibiotic will be in the Gatorade water mix and changed every three days.  Each group 
was assessed at a 14-day time point. 
 
In-vivo Femur Study 
Surgical Procedure 
All animal handling and surgical procedures were strictly conducted under the University 
of Tennessee Institutional Animal Care and Use Committee (IACUC).  
 
Each group consisted of 6 Sprague-Dawley rats 8-12 weeks old and weighing 
between 225 and 240g. A defect of critical size in the rat femur - measuring 5 mm of the 
hind limb of each rat was performed in a rotating format (Figure 5.1) will be used to 
evaluate the osteogenesis and angiogenesis of production by the scaffold. Each patient 
will be anesthetized with isoflurane at 1.5 to 2% with 2 L/min Oxygen by induction tank 
then placed on mask support for remaining time in the operating room. Once removed 
from the tank the patient was placed in a lateral position with procedure side up.  Before 
surgery, each rat will be given the analgesic buprenorphine (0.05 mg/kg) based on 
IACUC protocol. Next, removal of hair from the hindquarter, using small clippers.  The 
skin area was then prepped for sterility with chlorhexidine and alcohol. While holding the 
skin taught, using a sterile blade, make a longitudinal incision of about 12-15 mm, and 
the entire femoral shaft will be exposed using blunt dissection.  The fascia will be cut 
separating the tensor fascia lata and biceps femoris muscles, and the vastus lateralis 
muscle will be freed from the greater trochanter to the lateral femoral condyle.  2 cuts 
(one proximal and the other distal) in the middle of the diaphysis will be made, and a 
5mm bone segment will be cut and removed using a reciprocal saw.  The defect will be 
held in place using a 1.1 mm K-wire, which will be placed in the intramedullary cavity 
between the proximal and the distal ends of the defect. The K-wire is a thin, semi-stiff 





small diameter allows for its use in the rat model as a form of intramedullary nailing. The 
K-wire will be inserted into the 3D PLGA: Carbon-based nanoparticle biofabricated 
construct and then held at the proximal and distal locations. Suture the fascia overlying 
the muscle using 3.0-5.0 PDS resorbable sutures and close the wound. 
For the 7 days postoperative, the rats will be given buprenorphine injection every eight 
to twelve hours for pain management and antibiotic will be in the Gatorade water mix 
and changed every three days. 
Constructs receiving cells were placed in 10mm petri dish, then seeded with one million 
hADMSCs then placed in the incubator at 37oC 12-16 hours before surgery. This step 
will ensure that the cells impregnate the construct.  
 
Groups were formed for the study.    
Group 1 - PLGA 50:50/65:35+1.0mg Low Oxygen Graphene  
Group 2 - PLGA 50:50/75:25+1.0mg Low Oxygen Graphene 
Group 3 - PLGA 50:50/65:35+1.0mg Low Oxygen Graphene with human adipose-
derived mesenchymal stem cells 
Group 4 - PLGA 50:50/65:35+1.0mg Low Oxygen Graphene with human adipose-
derived mesenchymal stem cells 
  
Each group will be assessed at 60-day time point.  Rats from each treatment group will 
be euthanized at specified time point and bone healing will be evaluated with 
conventional radiological analysis, microcomputed tomography, histomorphometrically 
using H&E and von Kossa staining for use in the histological visualization of calcium 
deposits.  
 
Radiology analysis – Femur Study 
 A digital radiography system (Philips Easy Diagnost RF System; Cannon DR 
plates (CXDI-50G); EDR6 Clinical Diagnostic Radiography System) was used to assess 
bone healing. X-rays of the patients were taken 12 hours post-surgery to confirm correct 
K-wire and construct placement as well as to establish a base line for the study.  A 





and 60 days post-surgery to assess formation of newly formed mineralized bone tissue 
and changes within the segmental bridging.   
 
Microcomputed Tomography Imaging – Femur Study 
Micro-CT analysis is to provide data on the temporal progression of 
mineralization development during the regenerative process of the femur.  Preparation 
for micro-CT imaging, all femurs were stored in 10% formalin for 48 hours, then placed 
in cotton wrap soaked in 70% ethanol and stored in a 50mL conical tube for shipping.  
Femur specimens were sent to Roseman University of Health, College of Dental 
Medicine. Specimens were then processed using a desktop Micro-CT system (SkyScan 
1173, Bruketr Kontich, Belgium) to perform the evaluations.  The unit is equipped with a 
sample tube and aluminum filter, femurs were scanned at an energy of 80 kVp and 
intensity of 100 μA, resulting in a pixel size 31.99 μm and 1120 rows x 1120 columns.  
Each femur was placed in a cylinder and attached to holder with the femur oriented 
perpendicular to the image plane.   
3D data analysis of the full femur was evaluated.  The region of interest (ROI) 
was completed manually by drawing polygonal regions.  The analyzed ROI included the 
defect region and adjacent newly formed bone.  Analyses included tissue area, bone 
area, percent bone area / tissue area (bone volume density), trabecular thickness (Tb. 
Th), trabecular separation (Tb. Sp), trabecular number (Tb. N) and total porosity (Po 
total). Threshold values range of 45-65, 65-85, 85-105 and 105-255 were selected for 
segmentation of the PLGA/carbon-based nanoparticle construct and newly formed 
bone.  3D models were generated in CTAn and formed in a. stl format for visual 
representation.   
 
Histological and Immunohistochemistry Staining 
Intramuscular tissue surrounding the implant and femoral tissue from the critical 
size defect were prepared for histological examination.  Samples were sent to the 
appropriate labs for prep and cuts.  Extra slides were requested for in-house 
immunostaining.  Masson trichrome was to analyze surrounding connective tissue.  





von Willebrand Factor was used to analyze vessel density.  CD44 analyzed MSC 
recruitment to the construct site.   
 
Intramuscular Study 
  Samples were sent to the Ridge Microtome Services where samples were 
embedded in paraffin.  Hematoxylin and eosin (H&E) and Masson's trichrome staining 
was performed on deparaffinized sections to evaluate histological features with extra 
slides cut for inhouse IHC to be performed for osteogenic and endothelial markers.  For 
immunohistochemistry, Day 1 - paraffin sections were deparaffinized with xylene 2 
times for 20 minutes each and rehydrated with serial concentrations of ethanol gradient 
starting with 100%, then 95% then 70% at 5 minutes each all at room temperature. 
Subsequently, sections were rinsed in distilled water for 5 minutes.   
 Antigen retrieval steps: First, place samples Target Retrieval Solution (DAKO, 
Carpinteria, CA) at 80-85oC for 30 minutes; then, remove container with slides from 
water bath in DAKO solution allow to cool at room temperature for 20 minutes, then 
decant solution with PBS at room temperature for 5 minutes.   
 Primary antibody staining: Surround the samples on the slide with ImmEdge pen 
(Vector Laboratories, Burlingame, CA), next add 1% Triton X-100 in PBS solution into 
the circled area for 30 minutes at room temperature followed by PBS wash for 5 
minutes.  Incubate sample in Super Block (ScyTek Laboratories, Logan, UT) at room 
temperature for 30 minutes. Next add Primary Antibody Solution (Dilution in Super 
Block) at 200 L volume (In-house List Below); In house sections were incubated with 
the primarty antibody in humidified chambers at 4°C overnight.  
Ridge Microtome Services: 
1- Hematoxylin and eosin 
      2- Masson’s trichrome 
In-house Primary IHC: 
1- Fibronectin (1:100, abcam ab23751) 
2- Osteopontin (OPN) (1:100 abcam ab8448) 
3- Cluster of differentiation 44 (CD44) (1:200 abcam ab157107) 





5- Cluster of differentiation 31 (CD31) (1:200 LS-BIO LS-B12093) 
6- Cluster of differentiation 34 (CD34) (1:100 abcam ab185732) 
7- Sp7/Osterix (1:100 abcam ab22552) 
 
Day 2 – Remove primary antibody solution with a 1% PBS-TWEEN 20 wash for 5 
minutes.  Next, add Peroxidase Blocking Solution at room temp for 10 minutes followed 
by wash with PBS-TWEEN 20.  Next, add Goat anti-Rabbit IgG Biotinylated at 4 drops 
to each sample for 30 minutes room temp. Rinse with PBS-TWEEN 20 3 times 
carefully.  Now add Streptavidin Peroxidase (Vector Laboratories) at 4 drops to each 
sample at room temp for 30 minutes.  Rinse with 1x Tris Buffered Saline 3 times 
carefully. In separate beaker mix NovaRed Substrate Kit Peroxidase: 5mL of DI water,3 
drops Reagent 1, 2 drops Reagent 2, 2 drops Reagent 3, 2 drops Hydrogen Peroxide – 
add 200 L of mix to each sample for 15 minutes.  Rinse with PBS-TWEEN 20 2 times. 
 Day 2 - Phase III – Rinse slides with tap water, then immerse in Hematoxylin 
stain (Vector Laboratories) at room temp for 5 minutes, rinse with tap water until clear 
water is coming off sample.  Next Acid Rinse – Slides were then put into a glass holder 
and at a medium motion slides were moved up then down (dip) repeating 10 times 
(Motion may cause sample to lift off slide – watch carefully), then same motion in tap 
water 10 dips, move over to Bluing Solution for 5 dips, followed by tap water with 15 
dips.  Next, dehydrate slide in an ethanol gradient with 95% for 3 minutes then up to 
100% for 3 minutes, last move slide to xylene 2 times at 5 min each then lay slides to 
side for mounting.   
Mounting will be done with Limonene-mount (Electron Microscopy Sciences, Hatfield, 
PA) apply 2 drops then gently add 22x22x1mm coverslip – limiting bubbles to the 
sample viewing area or moving coverslip once applied.  Lay flat to dry overnight. 
 
Femur Study 
Samples were randomly divided into two groups of 12.  First twelve were sent to 
Ridge Microtome Services where samples were decalcified and the remaining twelve 
were sent to Ratliff Histology Consultants, LLC and prepped in calcified IHC cuts.    





trichrome staining with 7 extra slides cut for inhouse IHC staining.   Staining was 
performed with primary antibodies specific to osteogenic and endothelial markers.  
Same protocol followed from intramuscular study and ICH markers for decalcified femur 
samples.   
Ridge Microtome Services: 
1- Hematoxylin and eosin 
2- Masson’s trichrome  
In-house Primary IHC: 
1- Fibronectin (1:100, abcam ab23751) 
2- Osteopontin (1:100 abcam ab8448) 
3- Cluster of differentiation 44 (CD44) (1:200 abcam ab157107) 
4- Von Willebrand Factor (1:200 LS-BIO LS-B9918) 
5- Cluster of differentiation 31 (CD31) (1:200 LS-BIO LS-B12093) 
6- Cluster of differentiation 34 (CD34) (1:100 abcam ab185732) 
7- Sp7/Osterix (1:100 abcam ab22552) 
Ratliff Histology Consultants, LLC - Calcified sample stains: 
1- Von Kossa/MacNeal’s stain 




Surgical Postoperative – Intramuscular Study 
All 6 rats underwent the surgical procedure well.  All construct implants stayed within 
the muscle pouch and no discharge or swelling during the 14-day length of the study.  
All rats had a positive weight gain.  
 
Surgical Postoperative – Femur Study 
All 24 rats underwent the surgical procedure well.  All construct implants having the hole 
3D printed made allowed for a successful manipulation of the K-wire.  Postoperative 
recovery was successful without any complications in all the rats. Postoperative 





complications or infections throughout the sixty-day study.  All rats in both studies 
remained in good health during the experimental duration, with no signs of stress or hair 
loss and positive gaining of weight in the sixty-day period following surgery. 
 
Radiographic results – Femur study only 
Rats underwent protocol sedation at 24 hours, 7 days, 30 days and 60 days for tracking 
of implant and changes in bone structure.  Correct positioning in a lateral recumbent 
position of the limb containing the implant 24 hours post-surgery to check K wire 
position or any possible complications.   
 7 days post-surgery changes in bone formation both distal and proximal of the 
construct in both acellular and cellular constructs.  All rats were mobile still showing no 
signs of complications or depression.  Palpation of the limb was done showing complete 
mobility of the knee and hip regions.   
 One-month post-surgery a notice of some movement of the K-wire has taken 
place.  Various changes in bone structure on both sides of the construct implant.  Some 
outcropping or finger like projections showing signs of early stages of bone remodeling 
were beginning to show radio-opaque on the radiographs as well as changes in the 
medullary cavity.  Palpation of the limb showed no signs of mobility issues or swelling of 
tissue or redness to the sight and each rat was weight bearing and gaining weight.   
 Two months post-surgery, formation of new bone was observed in several rats 
and in both acellular and cellular groups but a higher bridging on bone and less 
remodeling in the medullary cavity in groups containing the 50:65 PLGA+ LOG. 
(Figures 5.2-5.9 shows representative comparisons for each iteration (a) Phantom 
(b) radiological view at 24 hours and 60-day end point (c) stl of each threshold of 
micro-CT).   
 
Micro-CT 
The unbiased technique is measuring bone at multiple densities. Multi-level 
thresholding is to evaluate bone mass at multiple density levels to reduce the difference 
of cortical bone from trabecular bone.  Femur analysis by micro-CT confirmed results in 





femur defects in both acellular and cellular groups showed some bony formation after 
60 days. Femurs with PLGA 50:65 acellular and cellular showed the highest values of 
newly formed bone.   3D stl reconstructions confirmed percent bone area / tissue area 
(bone volume density) showing a difference in both acellular and cellular groups.  The 
evaluating results for the complete threshold of 45 to 255 showed no significant change 
throughout the bone development of the construct (Figure 5.10). Next, I decided to 
evaluate possible bone development at each threshold by utilizing the percent bone 
area / tissue area and plotting against the intact phantom femur.  The stl images 
represents as an increase in threshold levels indicating formation of less dense bone to 
calcified cartilage to new bone modeling (Freeman, 2009).  These results showed that 
PLGA+LOG 50:65 had a higher performance than PLGA+LOG 50:75 (Figure 5.11) 
 
Immunohistochemistry and Histology 
Histological analyses were performed on all 6 Intramuscular and 24 femurs.  Routine 
staining by Masson’s Trichrome and Hematoxylin-Eosin for all sets. 
 
Intramuscular Immunohistochemistry 
 Samples of PLGA-LOG were removed from the muscle pouch site.  The study 
had an n=3 acellular and n=3 cellular using human adipose stem cell source.  
Observation of the H&E staining tissue-construct interface showed no signs of 
inflammatory response or bacterial infection.  Samples in both sets showed positive 
markers showing the cell communication with the biofabricated construct matrix.  
Cellular samples of CD 34 and vWF identified increased vascular frequency around the 
implant.  Marker CD 44 showed MSC recruitment potential by the construct.  
Osteogenic marker OPN suggested in the dark brown dense tissue around the 
construct indicated osteogenic response.  These results indicate the PLGA+LOG 
construct contains all properties for an osteoinductive material. (Figure 5.12 -5.13) 
 
Femur Immunohistochemistry 
Confirming the visual of radiological and micro-CT analysis, IHC confirmed that 





stain was used to visualize new bone formation with, and counter stained with 
MacNeal’s tetrachrome for unmineralized tissue. Calcified embedded sections showed 
amounts of von Kossa - mineralized tissue (black) within the defects and constructs 
(Figures 5.14 – 5.17).  In the cellular group’s greater amounts of mineralization and 
bridging were formed.  In figure 5.18 the statistical analysis of the von Kossa shows the 
50:65 LOG had a higher performance in the acellular construct and the 50:75 LOG 
construct was supported by the hADMSCs during the in vivo study.  Mesenchymal stem 
cells acquire the possibility of differentiating into osteoblast if environment ques are 
present or aid to the native osteoblast which is supported by Miro CT and 
histochemistry. The extracellular matrix protein fibronectin confirms cell to matrix 
communication and support by the construct in both acellular and cellular samples. 
Bone formation in both PLGA groups by endochondral ossification based on the amount 
cartilage templates formed and over period of development replaced by bone matrix 
(Figures 5.19 – 5.22) to confirm increased bone remodeling and bone formation, we 
performed immunostaining of OPN marker which expressed an enhanced response.  
Cellular marker CD44 confirmed MSC migration throughout the multilayer construct. 









 Double molar ratio blend PLGA plus LOG are novel alloplastic biofabricated 
constructs that will support bone enhancement procedures.  Within the limits of the 
study, osteogenesis was partially enhanced using the two different iterations in acellular 
and cellular when implanted into a critical sized rat femur defect.  Although numerous 
innovations over the last decades, this bone construct offers an equally dynamic 
combination of osteoconductive three-dimensional structure, osteogenic cells and 
osteoinductive growth factors with encouraging mechanical properties and could 
support and stimulate vascularization. The micro-CT and histology results of the study 
showed the iterations supported increased bone volume and under surgical conditions 
mechanical properties needed for a biofabricated implant.  Future growth on this study 
using the segmental femur defect over longer time points and various concentrations of 
graphene nanoparticles will hopefully allow for optimization to bone formations and 
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a.       
b.   
c.      
Figure 5.2. Overview of results Femur 1 50:65 PLGA-LOG Acellular – Decalcified. (a) shows phantom femur micro-CT scan 
with stl of ROI slices equal to all samples. (b) 24-hour X-ray of Rat 1 Femur 50:65 acellular and 60-day post X-ray. (c) (1) 
micro-CT femur 1 with stl views of bone growth around the PLGA-LOG construct – (c2) Threshold 45-65, (c3) Threshold 65-
85, (c4) Threshold 85-105 and (c5) Threshold 105-255. 
 





a.       
b.     
c.      
Figure 5.3. Overview of results Femur 4 50:65 PLGA-LOG Acellular – Calcified. (a) shows phantom femur micro-CT scan 
with stl of ROI slices equal to all samples. (b) 24-hour X-ray of Rat 4 Femur 50:65 acellular and 60-day post X-ray. (c) 
micro-CT femur 4 with stl views of bone growth around the PLGA-LOG construct – (c2) Threshold 45-65, (c3) Threshold 
65-85, (c4) Threshold 85-105 and (c5) Threshold 105-255. 





a.       
b.  
c.      
Figure 5.4. Overview of results Femur 7 50:75 PLGA-LOG Acellular – Decalcified. (a) shows phantom femur micro-CT 
scan with stl of ROI slices equal to all samples. (b) 24-hour X-ray of Rat 7 Femur 50:75 acellular and 60-day post X-ray. 
(c) micro-CT femur 7 with stl views of bone growth around the PLGA-LOG construct – (c2) Threshold 45-65, (c3) 
Threshold 65-85, (c4) Threshold 85-105 and (c5) Threshold 105-255. 
  





a.       
b.   
c.      
Figure 5.5. Overview of results Femur 11 50:75 PLGA-LOG Acellular – Calcified. (a) shows phantom femur micro-CT 
scan with stl of ROI slices equal to all samples. (b) 24-hour X-ray of Rat 11 Femur 50:75 acellular and 60-day post X-ray. 
(c) micro-CT femur 11 with stl views of bone growth around the PLGA-LOG construct – (c2) Threshold 45-65, (c3) 
Threshold 65-85, (c4) Threshold 85-105 and (c5) Threshold 105-255. 
  





a.       
b   
c.      
Figure 5.6. Overview of results Femur 15 50:65 PLGA-LOG Cellular – Decalcified. (a) shows phantom femur micro-CT 
scan with stl of ROI slices equal to all samples. (b) 24-hour X-ray of Rat 15 Femur 50:65 cellular and 60-day post X-ray. 
(c) micro-CT femur 15 with stl views of bone growth around the PLGA-LOG construct – (c2) Threshold 45-65, (c3) 
Threshold 65-85, (c4) Threshold 85-105 and (c5) Threshold 105-255. 
 
  





a.       
b.   
c.      
Figure 5.7. Overview of results Femur 19 50:65 PLGA-LOG Cellular – Calcified. (a) shows phantom femur micro-CT scan 
with stl of ROI slices equal to all samples. (b) 24-hour X-ray of Rat 19 Femur 50:65 cellular and 60-day post X-ray. (c) 
micro-CT femur 19 with stl views of bone growth around the PLGA-LOG construct – (c2) Threshold 45-65, (c3) Threshold 
65-85, (c4) Threshold 85-105 and (c5) Threshold 105-255.  
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a.       
b.   
c.      
Figure 5.8. Overview of results Femur 20 50:75 PLGA-LOG Cellular – Calcified. (a) shows phantom femur micro-CT scan 
with stl of ROI slices equal to all samples. (b) 24-hour X-ray of Rat 20 Femur 50:75 cellular and 60-day post X-ray. (c) 
micro-CT femur 20 with stl views of bone growth around the PLGA-LOG construct – (c2) Threshold 45-65, (c3) Threshold 
65-85, (c4) Threshold 85-105 and (c5) Threshold 105-255.  
2 1
 





a.       
b.   
c.      
Figure 5.9. Overview of results Femur 22 50:75 PLGA-LOG cellular – Decalcified. (a) shows phantom femur micro-CT 
scan with stl of ROI slices equal to all samples. (b) 24-hour X-ray of Rat 22 Femur 50:75 cellular and 60-day post X-ray. 
(c) micro-CT femur 22 with stl views of bone growth around the PLGA-LOG construct – (c2) Threshold 45-65, (c3) 
Threshold 65-85, (c4) Threshold 85-105 and (c5) Threshold 105-255. 
2 1
 






Figure 5.10. Results for the complete threshold of 45 to 255 showed no significant change throughout the bone 
























Figure 5.11. Results showing bone development at each threshold by utilizing the percent bone area / tissue area and 
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Figure 5.12. Representative image of the Intramuscular Osteoinductive Study Acellular Sample. Red arrows identify 
areas of antibody expression at the tissue-construct interface.    
Masson’s Trichrome
CD 44 CD 34
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Figure 5.13. Representative image of the Intramuscular Osteoinductive Study Cellular Sample.  Red arrows identify 
areas of antibody expression at the tissue-construct interface.   
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Figure 5.14. Representative image of Femur 4 Region of Interest 50:65 PLGA-LOG Acellular.  Representation of 
Calcified cuts stained with von Kossa MacNeal- mineralized bone expressed with black color and Goldner’s Masson 
Trichrome- collagen expressed with green color. Brown scale bar: 2000µm.  






Figure 5.15. Representative image of Femur 11 Region of Interest 50:75 PLGA-LOG Acellular.  Representation of 
Calcified cuts stained von Kossa MacNeal- mineralized bone expressed with black color and Goldner’s Masson 
Trichrome- collagen expressed with green color. Brown scale bar: 2000µm.  






Figure 5.16. Representative Image of Femur 19 Region of Interest 50:65 PLGA-LOG Cellular.  Representation of 
Calcified cuts stained von Kossa MacNeal- mineralized bone expressed with black color and Goldner’s Masson 
Trichrome- collagen expressed with green color. Brown scale bar: 2000µm. 
  






Figure 5.17. Representative Image of Femur 20 Region of Interest 50:75 PLGA-LOG Cellular.  Representation of 
Calcified cuts stained von Kossa MacNeal- mineralized bone expressed with black color and Goldner’s Masson 
Trichrome- collagen expressed with green color. Brown scale bar: 2000µm. 
  






5.18. von Kossa analysis of acellular vs cellular constructs.  Data shows that 50:75 LOG performs with cellular 
support and 50:65 LOG performs without cellular support in vivo.  
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Figure 5.19. Representative Image of Femur 1 Region of Interest 50:65 PLGA-LOG Acellular.  Representation of 
Decalcified cuts stained with Masson’s Trichrome, Immunohistochemical staining for ECM protein - Fibronectin, Osteo 











Figure 5.20. Representative Image of Femur 7 Region of Interest 50:75 PLGA-LOG Acellular.  Representation of 
Decalcified cuts stained with Masson’s Trichrome, Immunohistochemical staining for ECM protein - Fibronectin, Osteo 
marker -Osteopontin, Cell Markers CD44 and CD 34 with windows identifying expression of stain. Brown scale bar: 
2000µm. 
Masson’s Trichrome







Figure 5.21. Representative Image of Femur 15 Region of Interest 50:65 PLGA-LOG Cellular.  Representation of 
Decalcified cuts stained with Masson’s Trichrome, Immunohistochemical staining for ECM protein - Fibronectin, Osteo 
marker - Osteopontin, Cell Markers CD44 and CD 34 with windows identifying expression of stain. Brown scale bar: 
2000µm. 
Masson’s Trichrome







Figure 5.22. Representative Image of Femur 22 Region of Interest 50:75 PLGA-LOG Cellular.  Representation of 
Decalcified cuts stained with Masson’s Trichrome, Immunohistochemical staining for ECM protein - Fibronectin, Osteo 
marker -Osteopontin, Cell Markers CD44 and CD 34 with windows identifying expression of stain. Brown scale bar: 
2000µm. 
Masson’s Trichrome













CONCLUSIONS AND FUTURE DEVELOPMENTS 
 
This thesis presents a characterization of the relationship of MSCs 
working with graphene nanoparticles, then forming a blended PLGA-graphene 
cylindrical construct using the additive manufacturing technique 3D bioprinting for 
biofabrication in bone tissue engineering.    The material design for the 3D 
constructs utilizing a PLGA matrix, which provides cellular support for ECM 
production during the organic phase, reinforced with LOG nanoparticles, which 
supports the ECM transfer of cells in the mineral phase of the regenerative 
development.   
 The first part of the design was showing that undifferentiated MSCs would 
support a relationship and longevity on 2D films of LOG.  The important 
component consisted of the blending and characterization of the PLGA-LOG for 
printing on the Aether1 bioprinter.  The use of DMSO changed the approach at 
many levels using two molar ratios of PLGA and a nanoparticle.  Characterization 
consisted in fiber width, using various conical nozzles and a continuous pressure 
and speed settings.  Those results were used to establish a printing protocol to 
meet all parameters to find the best pressure and speed combination that could 
provide a fiber at 0.2mm diameter.   
 As the construct building blocks came together, samples were printed at 
0.5mm high and 5mm in diameter and were sterilized in multiple methods to 
check material stability.  Cell viability was measured with Calcein-AM and 
showed positive results which allowed to move to seeding constructs with 
transduced MSCs for biocompatibility, proliferation and migrations up to the 21-
day time point.  The results showed that the blend using DMSO did not have a 
negative effect on long term cell patterns.   The final study was implanting the 
5mm x 5mm construct into a 5mm critical sized segmental femur defect to show 
in vivo compatibility.  This work opened the door to many questions and many 






3D bioprinting has encountered accelerated progress over the last five years.  
Future developments of the research deal with material, construct and biological 
aspects.   
 
Material development:  Various combinations of single ratios and multimaterial 
printing outside this study and various concentrations of LOG and rGO need to 
be studied.  This could increase mechanical and biological enhancement and 
optimize topological ques for cellular ECM enrichment. 
 
Construct developments: Multimaterial extrusion allows for biofabricating 
complex architecture with rapid and smooth transition between divergent 
biomaterials.  Porosity is very important to the whole process which depends on 
fiber distance and layer and angle orientation.   If any variance in those 
parameters, porosity dimensions and geometrical output will vary as well allowing 
for analysis of various cell lines.  Construct geometry can impact mechanical 
behavior. 
 
Biological developments: Multiple methodologies can be used to proceed in 
biological investigations.  Further studies on various stem cell lines and co-
culturing would greatly support the construct’s ability to be studied for an ECM 
matrix for multiple organs.   Bioprinting 3D tissue models for simulation of a 
disease environment for clinical studies could be utilized.  This will allow for open 
access to the 4D bioprinting of dynamic tissues with designs in programmable 
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